<!DOCTYPE html>
<html lang="en" class="pb-page"  data-request-id="a5499516-1d15-4cb5-95dd-2f58dd714334"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";journal:journal:lancet;ctype:string:Journal Content;pageGroup:string:Article View;requestedJournal:journal:lancet;page:string:Show Full Text;product:product:elsevier\:product\:lancet;wgroup:string:Default Website Group;article:article:pii\:S0140673620311806;website:website:lancet-site;csubtype:string:Ahead of Print"/>




<!-- if there is any customization for Responsive Project widget  -->

















        <meta name="robots" content="noarchive"/>
<meta name="pb-robots-disabled">
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1"/>









        <meta property="og:title" content="Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" />
    


        <meta property="og:type" content="Article" />
    


        <meta property="og:url" content="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/abstract" />
    



        <meta property="og:site_name" content="The Lancet" />
    


        <meta property="og:image" content="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/cbedc4e7-a79c-42d0-8b51-55e387baadef/gr1.gif" />
    


        <meta property="og:description" content="We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used
alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug
regimens was associated with decreased in-hospital survival and an increased frequency
of ventricular arrhythmias when used for treatment of COVID-19." />
    







        <meta name="twitter:title" content="Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" />
    




        <meta name="twitter:image" content="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/cbedc4e7-a79c-42d0-8b51-55e387baadef/gr1.gif" />
    


        <meta name="twitter:description" content="We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used
alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug
regimens was associated with decreased in-hospital survival and an increased frequency
of ventricular arrhythmias when used for treatment of COVID-19." />
    



    <meta name="apple-itunes-app" content="app-id=483025114"/>


    <meta name="google-play-app" content="app-id=com.elsevier.jbsm.lancet" />


    <meta name="AppTitle" content="The Lancet"/>


    <meta name="AppAuthor" content="Elsevier Inc."/>


    <meta name="AppIconUrl" content="http://www.thelancet.com.marlin-prod.literatumonline.com/pb-assets/Lancet/Images/lancetLogo.png"/>



<title>Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis - The Lancet</title><meta name="citation_journal_title" content="The Lancet"/> <meta name="citation_journal_abbrev" content="The Lancet"/> <meta name="citation_publisher" content="Elsevier"/> <meta name="citation_title" content="Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"/> <meta name="citation_online_date" content="2020/05/22"/> <meta name="citation_volume" content="0"/> <meta name="citation_issue" content="0"/> <meta name="citation_abstract_html_url" content="http://www.thelancet.com/article/S0140673620311806/abstract"/> <meta name="citation_fulltext_html_url" content="http://www.thelancet.com/article/S0140673620311806/fulltext"/> <meta name="citation_pdf_url" content="http://www.thelancet.com/article/S0140673620311806/pdf"/> <meta name="citation_issn" content="0140-6736"/> <meta name="citation_issn" content="1474-547X"/> <meta name="citation_language" content="English"/> <meta name="citation_doi" content="10.1016/S0140-6736(20)31180-6"/> <meta name="citation_author" content="Mandeep R Mehra"></meta> <meta name="citation_author_email" content="mmehra@bwh.harvard.edu"></meta> <meta name="citation_author_institution" content="Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA, USA"></meta> <meta name="citation_author" content="Sapan S Desai"></meta> <meta name="citation_author_institution" content="Surgisphere Corporation, Chicago, IL, USA"></meta> <meta name="citation_author" content="Frank Ruschitzka"></meta> <meta name="citation_author_institution" content="University Heart Center, University Hospital Zurich, Zurich, Switzerland"></meta> <meta name="citation_author" content="Amit N Patel"></meta> <meta name="citation_author_institution" content="Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA"></meta> <meta name="citation_author_institution" content="HCA Research Institute, Nashville, TN, USA"></meta> <meta name="citation_reference" content="citation_title=Chloroquine or hydroxychloroquine for prophylaxis of COVID-19; citation_author=N Principi; citation_author=S Esposito; citation_journal_title=Lancet Infect Dis; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19; citation_author=C Perricone; citation_author=P Triggianese; citation_author=E Bartoloni; citation_author=et al.; citation_journal_title=J Autoimmun; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro; citation_author=J Liu; citation_author=R Cao; citation_author=M Xu; citation_author=et al.; citation_journal_title=Cell Discov; citation_volume=6; citation_firstpage=16; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?; citation_author=CA Devaux; citation_author=JM Rolain; citation_author=P Colson; citation_author=D Raoult; citation_journal_title=Int J Antimicrob Agents; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial; citation_author=W Tang; citation_author=Z Cao; citation_author=M Han; citation_author=et al.; citation_journal_title=medRxiv; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19; citation_author=J Chen; citation_author=D Liu; citation_author=L Liu; citation_author=et al.; citation_journal_title=J Zhejiang Univ (Med Sci); citation_volume=49; citation_firstpage=215; citation_lastpage=219; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial; citation_author=P Gautret; citation_author=JC Lagier; citation_author=P Parola; citation_author=et al.; citation_journal_title=Int J Antimicrob Agents; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Azithromycin and the risk of cardiovascular death; citation_author=WA Ray; citation_author=KT Murray; citation_author=K Hall; citation_author=PG Arbogast; citation_author=CM Stein; citation_journal_title=N Engl J Med; citation_volume=366; citation_firstpage=1881; citation_lastpage=1890; citation_publication_date=2012; "></meta> <meta name="citation_reference" content="citation_title=Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19); citation_author=JR Giudicessi; citation_author=PA Noseworthy; citation_author=PA Friedman; citation_author=MJ Ackerman; citation_journal_title=Mayo Clin Proc; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Possible consequences of a shortage of hydroxychloroquine for patients with systemic lupus erythematosus amid the COVID-19 pandemic; citation_author=CA Peschken; citation_journal_title=J Rheumatol; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Clinical management of severe acute respiratory infection (SARI) when novel COVID-19 disease is suspected: interim guidance; citation_author=WHO; citation_publication_date=March 13, 2020; "></meta> <meta name="citation_reference" content="citation_title=Emergency use authorization: coronavirus disease 2019 (COVID-19) EUA information; citation_author=US Food and Drug Administration; "></meta> <meta name="citation_reference" content="citation_title=Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies; citation_author=J Gao; citation_author=Z Tian; citation_author=X Yang; citation_journal_title=Biosci Trends; citation_volume=14; citation_firstpage=72; citation_lastpage=73; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19; citation_author=J Magagnoli; citation_author=S Narendran; citation_author=F Pereira; citation_author=et al.; citation_journal_title=medRxiv; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection with oxygen requiremenr: results of a study using routinely collected data to emulate a target trial; citation_author=M Mahevas; citation_author=V-T Tran; citation_author=M Roumier; citation_author=et al.; citation_journal_title=medRxiv; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells; citation_author=M Traebert; citation_author=B Dumotier; citation_author=L Meister; citation_author=P Hoffmann; citation_author=M Dominguez-Estevez; citation_author=W Suter; citation_journal_title=Eur J Pharmacol; citation_volume=484; citation_firstpage=41; citation_lastpage=48; citation_publication_date=2004; "></meta> <meta name="citation_reference" content="citation_title=Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China; citation_author=S Shi; citation_author=M Qin; citation_author=B Shen; citation_author=et al.; citation_journal_title=JAMA Cardiol; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19); citation_author=T Guo; citation_author=Y Fan; citation_author=M Chen; citation_author=et al.; citation_journal_title=JAMA Cardiol; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality; citation_author=RO Bonow; citation_author=GC Fonarow; citation_author=PT O'Gara; citation_author=CW Yancy; citation_journal_title=JAMA Cardiol; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Cardiovascular disease, drug therapy, and mortality in COVID-19; citation_author=MR Mehra; citation_author=SS Desai; citation_author=S Kuy; citation_author=TD Henry; citation_author=AN Patel; citation_journal_title=N Engl J Med; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Endothelial cell infection and endotheliitis in COVID-19; citation_author=Z Varga; citation_author=AJ Flammer; citation_author=P Steiger; citation_author=et al.; citation_journal_title=Lancet; citation_volume=395; citation_firstpage=1417; citation_lastpage=1418; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal; citation_author=HK Siddiqi; citation_author=MR Mehra; citation_journal_title=J Heart Lung Transplant; citation_volume=39; citation_firstpage=405; citation_lastpage=407; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro; citation_author=S Nakornchai; citation_author=P Konthiang; citation_journal_title=Acta Trop; citation_volume=100; citation_firstpage=185; citation_lastpage=191; citation_publication_date=2006; "></meta> <meta name="citation_reference" content="citation_title=Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: a randomized controlled trial; citation_author=N Lee; citation_author=CK Wong; citation_author=MCW Chan; citation_author=et al.; citation_journal_title=Antiviral Res; citation_volume=144; citation_firstpage=48; citation_lastpage=56; citation_publication_date=2017; "></meta> <meta name="citation_reference" content="citation_title=Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial; citation_author=MGS Borba; citation_author=FFA Val; citation_author=VS Sampaio; citation_author=et al.; citation_journal_title=JAMA Netw Open; citation_volume=3; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19); citation_author=NJ Mercuro; citation_author=CF Yen; citation_author=DJ Shim; citation_author=et al.; citation_journal_title=JAMA Cardiol; citation_publication_date=2020; "></meta> <meta name="citation_reference" content="citation_title=Management of cardiovascular diseases in patients with obesity; citation_author=CJ Lavie; citation_author=R Arena; citation_author=MA Alpert; citation_author=RV Milani; citation_author=HO Ventura; citation_journal_title=Nat Rev Cardiol; citation_volume=15; citation_firstpage=45; citation_lastpage=56; citation_publication_date=2018; "></meta> <meta name="citation_reference" content="citation_title=Obesity and outcomes in COVID-19: when an epidemic and pandemic collide; citation_author=F Sanchis-Gomar; citation_author=CJ Lavie; citation_author=MR Mehra; citation_author=BM Henry; citation_author=G Lippi; citation_journal_title=Mayo Clin Proc; citation_publication_date=2020; "></meta> <meta name="citation_abstract" content="&lt;h2&gt;Summary&lt;/h2&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;p&gt;Hydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19, despite no conclusive evidence of their benefit. Although generally safe when used for approved indications such as autoimmune disease or malaria, the safety and benefit of these treatment regimens are poorly evaluated in COVID-19.&lt;/p&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;p&gt;We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. The registry comprised data from 671 hospitals in six continents. We included patients hospitalised between Dec 20, 2019, and April 14, 2020, with a positive laboratory finding for SARS-CoV-2. Patients who received one of the treatments of interest within 48 h of diagnosis were included in one of four treatment groups (chloroquine alone, chloroquine with a macrolide, hydroxychloroquine alone, or hydroxychloroquine with a macrolide), and patients who received none of these treatments formed the control group. Patients for whom one of the treatments of interest was initiated more than 48 h after diagnosis or while they were on mechanical ventilation, as well as patients who received remdesivir, were excluded. The main outcomes of interest were in-hospital mortality and the occurrence of de-novo ventricular arrhythmias (non-sustained or sustained ventricular tachycardia or ventricular fibrillation).&lt;/p&gt;&lt;h3&gt;Findings&lt;/h3&gt;&lt;p&gt;96 032 patients (mean age 53·8 years, 46·3% women) with COVID-19 were hospitalised during the study period and met the inclusion criteria. Of these, 14 888 patients were in the treatment groups (1868 received chloroquine, 3783 received chloroquine with a macrolide, 3016 received hydroxychloroquine, and 6221 received hydroxychloroquine with a macrolide) and 81 144 patients were in the control group. 10 698 (11·1%) patients died in hospital. After controlling for multiple confounding factors (age, sex, race or ethnicity, body-mass index, underlying cardiovascular disease and its risk factors, diabetes, underlying lung disease, smoking, immunosuppressed condition, and baseline disease severity), when compared with mortality in the control group (9·3%), hydroxychloroquine (18·0%; hazard ratio 1·335, 95% CI 1·223–1·457), hydroxychloroquine with a macrolide (23·8%; 1·447, 1·368–1·531), chloroquine (16·4%; 1·365, 1·218–1·531), and chloroquine with a macrolide (22·2%; 1·368, 1·273–1·469) were each independently associated with an increased risk of in-hospital mortality. Compared with the control group (0·3%), hydroxychloroquine (6·1%; 2·369, 1·935–2·900), hydroxychloroquine with a macrolide (8·1%; 5·106, 4·106–5·983), chloroquine (4·3%; 3·561, 2·760–4·596), and chloroquine with a macrolide (6·5%; 4·011, 3·344–4·812) were independently associated with an increased risk of de-novo ventricular arrhythmia during hospitalisation.&lt;/p&gt;&lt;h3&gt;Interpretation&lt;/h3&gt;&lt;p&gt;We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.&lt;/p&gt;&lt;h3&gt;Funding&lt;/h3&gt;&lt;p&gt;William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women&#039;s Hospital.&lt;/p&gt;"></meta><meta charset="UTF-8" /><!--

    Pagebuild admin UI
-->





<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/itai~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/itai~selected-legacy.css"/>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans"/>
        
            <link rel="stylesheet" type="text/css" href="/products/marlin/lancet/releasedAssets/css/build.css"/>
        




<script rel="preconnect" src="//assets.adobedtm.com/376c5346e33126fdb6b2dbac81e307cbacfd7935/satelliteLib-8e350dc4ceceb17a5d77c03f66d95608807a5585.js"></script>

<script async src="https://www.youtube.com/iframe_api"></script>

<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">






    







    
        
    


















































    
        <script type="text/javascript">
            function optimizelyTimeout() {
                window.optimizely = window.optimizely || [];
                if (!window.optimizely.data) {
                    window.optimizely.push("timeout")
                }
            }
            (function () {
                var e = "https:" == document.location.protocol ? "https://" : "http://";
                var t = document.createElement("script");
                t.type = "text/javascript";
                t.async = true;
                t.src = e + "cdn.optimizely.com/js/537300906.js";
                var n = document.getElementsByTagName("script")[0];
                n.parentNode.insertBefore(t, n)
            })();
            setTimeout(optimizelyTimeout, 1e3)
        </script>
    



<script type="text/javascript" async src="//s7.addthis.com/js/250/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#pageBody"
                  id="skipNavigationLink"
                  title="Skip to Main Content" tabIndex="0">Skip to Main Content</a>
    </div>


<script type="text/javascript">

        if(true) {
            document.getElementById("skipNavigationLink").onclick =function skipElement () {
                document.getElementById('pageBody').setAttribute('tabindex','0');
                document.getElementById('pageBody').focus();
            }

        }

</script>


    <script type="text/javascript" async defer
            src="//cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>



    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="5019c3ed-aeec-4bec-a97a-cd7d6ecea46c" class="ux3">
        
    

        


    

            

            
                <div class="lancet">
            

            <div data-widget-id="5019c3ed-aeec-4bec-a97a-cd7d6ecea46c" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<script type="text/javascript">

	var gptadslots=[];
	var googletag = googletag ||
	{
	};

	googletag.cmd = googletag.cmd || [];

	(function()
		{
			var gads = document.createElement('script');

			gads.async = true; gads.type = 'text/javascript';

			var useSSL = 'https:' == document.location.protocol;

			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';

			var node = document.getElementsByTagName('script')[0];

			node.parentNode.insertBefore(gads, node);

		})();

</script>

<script type="text/javascript">
	//--------------------------------------------------------------------------
	$(document).ready(function ()
		{
			//Once the dom has loaded, begin the process to init the ads.
			gpt_InitAds();
		});
	//--------------------------------------------------------------------------
	function GPT_CheckForNULL(x, valueifnull) {
	    if (typeof valueifnull == "undefined") { valueifnull = null; }

	    if (typeof x == 'undefined') {
	        return valueifnull;
	    }
	    if (x == null) {
	        return valueifnull;
	    }
	    if (x == "null") {
	        return valueifnull;
	    }
	    if ($.trim(x) == '') {
	        return valueifnull;
	    }
	    else {
	        return x;
	    }
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting()
	{
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function( index )
			{
				var gptTargetId = $(this).attr('id');
				gptTargetId = gptTargetId.replace('gpt','').toLowerCase();
				if(gptTargetId!='')
				{
					gpt_Target(gptTargetId);
				}
			})
    }
    //--------------------------------------------------------------------------
    function gpt_TargetAccessType() {
        var currentAccessType = $('#gptAccessType').val();
        if (typeof currentAccessType == "undefined") {
            currentAccessType = "";
        }
        if (currentAccessType.indexOf('ANON_IP') >= 0) {
            googletag.pubads().setTargeting("loggedin", "yes");
        }
        else {
            gpt_Target("LoggedIn");
        }
    }
    //--------------------------------------------------------------------------
    function gpt_CheckForStaging() {
        //Check to see if we are on the marlin-stag env
        //if so, set a targeting value
        if (window.location.hostname.toLowerCase().indexOf('.marlin-stag.') >= 0) {
            $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="marlin-stag">');
            gpt_Target("Environment");
        }
    }    
	//--------------------------------------------------------------------------
	function enableStickySideBar(){
		var stickyStatus = 0;
		var scrollx, skytop, voffset;
		skytop = $(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-verticalAd").offset().top;

		$(window).scroll(function() {
			if (stickyStatus == 1) {
				if (rightColHeight != $(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-verticalAd").parent().height()) {
			        rightColHeight = $(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-verticalAd").parent().height();
			        skytop = $(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-verticalAd").offset().top;
				}
			}

			scrollx = $(window).scrollTop();

			// IF THE LEADERBOARD AD IS FIXED
			if ($(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-horizontalAd").css("position") == "fixed") {
				voffset = 110;
			} else {
				voffset = 0;
			}

			if ($("#jbs-fixed-hdr").length!=0){
				if ($("#jbs-fixed-hdr").css("display") == "block") {
				    voffset += $("#jbs-fixed-hdr").outerHeight();
				}
			}

			if (scrollx >= (skytop-voffset)) {   // MAKE AD IN RIGHT COLUMN STICKY
				var tmpWidth;
				tmpWidth = $(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-verticalAd").width();
				$(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-verticalAd").attr("style","top: " + voffset + "px !important;position: fixed !important;display:block !important;width:" + tmpWidth + "px !important;");
			} else {       // REVERT BACK TO ORIGINAL AD PLACEMENT
				$(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-verticalAd").attr("style","position: static !important; display:block !important;");
				skytop = $(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-verticalAd").offset().top;
				stickyStatus = 0;
			}
		});
	}
	//--------------------------------------------------------------------------
	function handleStickyLeaderboard()
	{
		var forceStickyLeaderboard = gpt_GetQuerystring('forcestickyleaderboard',0);
		if(forceStickyLeaderboard==0){
			// THIS FUNCTION REMOVES THE STICKY FEATURE OF THE LEADERBOARD
			$("#pb-page-content").attr("style","margin-top:0 !important;");
			$(".widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-horizontalAd").attr("style","margin-top: 0px !important;position: static !important;display:block !important;background-color: transparent;padding:0;");

			$("#jbs-fixed-hdr").attr("style","top: 0 !important;");

			if ($(".denialInfo").length === 0 && $("#jbs-fixed-hdr").length > 0)
			{
				var topY = window.pageYOffset;
				if (topY > 300)
				{
					$("#jbs-fixed-hdr").attr("style","top: 0 !important;display:block !important");
				}
			}
			$(window).scroll();
		}
	}
	//--------------------------------------------------------------------------
	function handleStickyLeaderboard_CELL()
	{
		var forceStickyLeaderboard = gpt_GetQuerystring('forcestickyleaderboard',0);
		if(forceStickyLeaderboard==0){
			$("body").attr("style","padding-top:10px !important;");
			$(".cell-top-head").first().attr("style","margin-top: 0px !important;position: static !important;display:block !important;background-color: transparent;padding:0;");
			$(".article.enhanced .tab-nav").addClass("resetTop0");
			$(".article.enhanced #fixedPane").addClass("resetTop38");
			$(".article.enhanced .fixedArticle > .tab-nav").css("top","0px");
			$(".article.enhanced .fixedArticle #fixedPane").css("top","38px");
			var tmpStyle;
			tmpStyle = $(".article.enhanced .tab-nav").attr("style");
			tmpStyle = "top:0px;" + tmpStyle;
			$(".article.enhanced .tab-nav").removeAttr("style");
			$(".article.enhanced .tab-nav").attr("style",tmpStyle);
			tmpStyle = $(".article.enhanced #fixedPane").attr("style");
			tmpStyle = "top:38px;" + tmpStyle;
			$(".article.enhanced #fixedPane").removeAttr("style");
			$(".article.enhanced #fixedPane").attr("style",tmpStyle);
			$(".skip").addClass("skip-post-stickyleaderboard");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_)
	{
		//function to read querystring variables
		if (default_ == null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs == null)
		return default_;
		else
		return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId()
	{
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid','');
		if(gptDFPTestId != '')
		{
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName)
	{
		//Set page level target if value is found
		if($('#gpt' + targetName).length>0)
		{
			var targetValue = $('#gpt' + targetName).val();

			if(targetValue!='')
			{
				targetValue = targetValue.replace(/[^-a-z0-9]/ig,'');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(),targetValue.toLowerCase());
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds()
	{
		var disableStickyLeaderboard = 0;
		var disableStickySidebar = 0;
		var responsiveDesign = 0;

		// ux3 Class will only exist if the page is Responsive Design
		if ($('.ux3').length!=0) {
			//Responsive Design Found, so disable the sticky Leaderboard
			responsiveDesign = 1;
			disableStickyLeaderboard = 1;
		}
		else{
			//Page is not responsive so check for Disable on Querystring
			disableStickyLeaderboard = gpt_GetQuerystring('disableStickyLeaderboard',0);
		}

		if(disableStickyLeaderboard!=0){
			//Disable the sticky leaderbard
			//Check for page flag, if it does not exist, create it.
			if($('#disableStickyLeaderboard').length==0){
				$("body").append("<div id='disableStickyLeaderboard'></div>");
			}
		}

		if(responsiveDesign==1){
			//Page is responsive design, check if it is an article page
			if($("[data-widget-def='UX3articleContent']").length!=0){
				//Its an article page, disable the sticky sidebar
				disableStickySidebar = 1;
			}
		}
		if(disableStickySidebar==0){
			//Check for disableStickySidebar in Querystring
			disableStickySidebar = gpt_GetQuerystring('disableStickySidebar',0);
		}

		if(disableStickySidebar!=0){
			//Disable the sticky leaderbard
			//Check for page flag, if it does not exist, create it.
			if($('#disableStickySidebar').length==0){
				$("body").append("<div id='disableStickySidebar'></div>");
			}
		}

		//Load common stylesheet for all sites except Cell & Responsive Design
		if($('.cell-site-header').length==0 && responsiveDesign==0){
			$("body").append('<link href="/pb-assets/shared/leaderboards/gpt_jbs-1504880817473.css" rel="stylesheet" />');
		}

		googletag.cmd.push(function()
			{
				var gptAdSlots = [];

				//***********************************************
				//Start Define Size mapping based on client Viewport
				//***********************************************
				var gptLeaderboardSizeMapping = googletag.sizeMapping().
				addSize([768, 0], [[728, 90]]). 								// Leaderboard
				addSize([0, 0], [[320, 50], [300, 50]]). 						// Mobile Leaderboard
				build();

				var gptSideBarSizeMapping = googletag.sizeMapping().
        addSize([1140, 800], [[160, 600], [300, 250]]). 				// SkyScraper - Desktop (Require min 800 vertical), Fall back to Boombox
				addSize([1140, 450], [[300, 250]]). 							// BoomBox - Desktop (Require min 450 vertical)
				addSize([0, 0], []). 											// Phone-Tablet
				build();

				var gptSideBarNotResponsiveSizeMapping = googletag.sizeMapping().
        addSize([1140, 800], [[160, 600]]). 				// SkyScraper - Desktop (Require min 800 vertical)
				addSize([0, 0], []). 											// Phone-Tablet
				build();

				var gptSideBarNotStickySizeMapping = googletag.sizeMapping().
        addSize([1140, 800], [[160, 600], [300, 250]]). 				// SkyScraper Not Sticky (Require min 800 vertical), Fall back to Boombox
				addSize([1140, 450], [[300, 250]]). 							// BoomBox Not Sticky (Require min 450 vertical)
				addSize([0, 0], []). 											// Phone-Tablet
				build();


				//***********************************************
				//End Define Size mapping based on client Viewport
				//***********************************************

				//***********************************************
				//Start detection for ad slots on page
				//***********************************************
				$(".gpt-ad").each(function( index )
					{
						var gptSite = GPT_CheckForNULL($('#gptSite').val());
						var gptPage = '';
						var adSizeMapping='';
						var adId;
						var gptPOS;
						var gptMasterPage = GPT_CheckForNULL($('#gptPage').val());

						if (gptSite == null) {
							gptSite = GPT_CheckForNULL($('#gptAltSite').val());
							if (gptSite == null) {
								gptSite = GPT_CheckForNULL($(this).data('site'));
							}
						}
						if (gptSite == null) {
							gptSite = GPT_CheckForNULL($('#gptDefaultSite').val());
						}
						if(gptSite!=null){
							adId = 'gpt-ad-' + index + 1;

							gptPOS = parseInt($(this).data('pos')) || -1;
							if(gptPOS == -1){
								gptPOS = index + 1;
							}

                            if (gptMasterPage != null) {
                                gptPage = '/' + gptMasterPage;
                            }
                            else {
                                gptPage = GPT_CheckForNULL($(this).data('page'));
                                if (gptPage != null) {
                                    gptPage = '/' + gptPage;
                                }
                                else {
                                    gptPage = '';
                                }
                            }

							//Determine sizemapping based on data-adsize
							switch($(this).data('adsize'))
							{
								case 'cell-leaderboard':
									adSizeMapping = gptLeaderboardSizeMapping;
									if(gptPOS==1){
										$(this).addClass('GPT-Leaderboard-Cell');
									}
									break;
								case 'leaderboard':
									adSizeMapping = gptLeaderboardSizeMapping;
									$(this).addClass('GPT-Leaderboard');
									break;
								case 'boombox':
									adSizeMapping = gptBoomBoxSizeMapping;
									break;
								case 'skyscraper':
									if($(this).hasClass("disableStickySidebar")){
										adSizeMapping = gptSideBarNotStickySizeMapping;
									}
									else{
										$(this).addClass('GPT-StickySideBar');
										adSizeMapping = gptSideBarSizeMapping;
									}
								break;
								case 'skyscrapernotresponsive':
									adSizeMapping = gptSideBarNotResponsiveSizeMapping;
									break;
							}
						}

						//Ignore any invalid adsizes that could be on the page
						if(adSizeMapping!='')
						{
							$(this).addClass('gpt-ad-defined');
							$(this).attr('id',adId);
							gptAdSlots[index] = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [], adId).defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);
						}
						else
						{
							$(this).remove();
						}
					});
				//***********************************************
				//End detection for ad slots on page
				//***********************************************

                //***********************************************
                //Start page level targeting
                //***********************************************
                //Logged in or IP Access
                gpt_TargetAccessType();

                //Check for DFP Test
                gpt_GetDFPTestId();

                //Check for Staging
                gpt_CheckForStaging();

                //Check for Additional Targeting
                gpt_GetAdditionalTargeting()

                //***********************************************
                //End page level targeting
                //***********************************************

				//Enable google dfp services
				googletag.pubads().enableSingleRequest();
				googletag.pubads().collapseEmptyDivs();
				googletag.enableServices();

				//Add Listener for Leaderboard
				googletag.pubads().addEventListener('slotRenderEnded', function(event)
					{
						if (!event.isEmpty)
						{
							$('#' + event.slot.getSlotElementId()).closest(".GPT-ad-placeholder").css("display", "block");


							//Sticky LeaderBoard JBS
							if ($('#' + event.slot.getSlotElementId()).hasClass("GPT-Leaderboard"))
							{
								if($('#disableStickyLeaderboard').length==0){
									$('body').addClass("hasLeaderboard");

									// INJECT SOME CSS FOR STICKY LEADERBOARD
									// THIS INCLUDES CHANGING THE TOP OF THE STICKY HEADER #jbs-fixed-hdr
									$("body").append("<style>.prevNextHeader:first-of-type,.skip{height:0}.widget.literatumAd.alignCenter.GPT-ad-placeholder.widget-horizontalAd{position:fixed;top:0;left:0;width:100%;background-color:#d8d8d8;padding:10px 0 0;margin:0px !important}#pb-page-content{margin-top:120px}#jbs-fixed-hdr{top:108px!important;z-index:999999!important;height:26px!important}.horizontalAd iframe{}div.horizontalAdContainer{height:95px!important}.iHubLinkContainerX{margin:0!important} div.horizontalAdContainer{height:90px !important;}</style>");

									setTimeout(handleStickyLeaderboard, 8000);
								}
							}

							//Sticky LeaderBoard Cell
							if ($('#' + event.slot.getSlotElementId()).hasClass("GPT-Leaderboard-Cell"))
							{
								if($('#disableStickyLeaderboard').length==0){
									$("body").append('<link href="/pb-assets/shared/leaderboards/gpt_cell-1504880817443.css" rel="stylesheet" />');
									$("div.cell-top-head").attr("style","display:block !important;"); $("body").append("");
									var tmp;
									tmp = $(".article.enhanced .tab-nav").attr("style");
									tmp = "top:110px;" + tmp;
									$(".article.enhanced .tab-nav").removeAttr("style");
									$(".article.enhanced .tab-nav").attr("style",tmp);
									tmp = $(".article.enhanced #fixedPane").attr("style");
									tmp = "top:148px;" + tmp;
									$(".article.enhanced #fixedPane").removeAttr("style");
									$(".article.enhanced #fixedPane").attr("style",tmp);
									setTimeout(handleStickyLeaderboard_CELL, 8000);
								}

								// THE FOLLOWING MAKES SURE THAT THE FIGURES PANE POPULATES
								// (there might be a bug on the live site)
								$("li.showFullText a").click();
							}


							//Sticky SideBar
							if ($('#' + event.slot.getSlotElementId()).hasClass("GPT-StickySideBar")){
								if($('#disableStickySidebar').length==0){
									enableStickySideBar();
								}
							}
						}
					});

				//Populate Defined Ad Slots
				$(".gpt-ad-defined").each(function( index )
					{
						var adId = $(this).attr('id');
						googletag.cmd.push(function() {googletag.display(adId);});
					});

			});
	}
</script>
<div id="gpt-Variables" data-adfile="LancetGPTSlot" data-version="02032020">
	<input type="hidden" id="gptSite" value="lancet">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
</div>

<!-- End: GPT -->

        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="f3868982-daa5-45e3-92f6-84fdcc4ac3fe" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

            

            

            <div data-widget-id="ff5ec9a2-0ea8-4f5e-aece-0786cac88a5c" data-widget-name="ux3-layout-widget"><div>
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="ccbf3208-3db1-4c0b-bb0d-eacad1af308a">
                
                

                <div class="wrapped " >
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement"/>
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <div class="gpt-ad" data-adsize="leaderboard"></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="4014114d-054d-414e-bb5e-ea626d9a028c" class="header__wrapper clearfix" data-db-parent-of="quickSearch">
        
    

        


    

            

            

            <div data-widget-id="4014114d-054d-414e-bb5e-ea626d9a028c" data-widget-name="ux3-layout-widget"><div class="col-xs-6">
    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="1f3f5ace-3a36-4970-a5f1-d69d6e7bf4b6" data-widget-name="ux3-general-image"><a href="/journals/lancet/home" title="The Lancet Journal"><img alt="The Lancet Journal" src="/pb-assets/ux3/logos/lancet/LANCET-1532516601370.svg"/></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="25bd95c4-9085-4b32-af0e-a8c71015a190" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <div data-widget-id="f133594e-2be9-4641-b3aa-38f20dd20d9d" data-widget-name="UX3MenuWidget" class="main-nav menu-drawer"><div class="menu-drawer__ctrl"><a href="#main-menu" data-target="main-menu" data-toggle="nav" title="Explore Lancet.com" aria-controls="main-menu" aria-expanded="false"><span class="menu-drawer--open"><i aria-hidden="true" class="icon-gizmo-hamburger"></i></span><span class="menu-drawer--close"><i aria-hidden="true" class="icon-close_thin"><span>Close</span></i></span></a></div><nav role="navigation" id="main-menu" data-ctrl-res="screen-sm" class="menu-drawer__nav drawer__nav gutterless"><span class="menu-drawer--holder hidden-md hidden-lg"></span><ul id="menubar" role="menubar" class="menubar rlist--inline"><li role="menuitem" aria-haspopup="true" aria-label="This Journal" id="menu-item-main-menu-0" class="dropdown menu-parent is--current"><a href="#" title="This Journal" id="main-menu-0" data-toggle="dropdown" class="dropdown__toggle"><span>This Journal</span><i aria-hidden="true" class="icon-arrow_r pull-right"></i></a><ul id="menu-items-0" role="menu" class="rlist dropdown__menu"><li role="menuitem" aria-haspopup="true" class="menu-drawer__back hidden-md hidden-lg"><a href="#" class="menu-drawer__back__ctrl"><i aria-hidden="true" class="icon-arrow_l"></i><span>Back</span></a></li><li role="menuitem" tabindex="-1" aria-label="Journal Home" class="menu-item"><a href="/journals/lancet/home" title="Journal Home"><span>Journal Home</span></a></li><li role="menuitem" tabindex="-1" aria-label="Online First" class="menu-item"><a href="/journals/lancet/onlineFirst" title="Online First"><span>Online First</span></a></li><li role="menuitem" tabindex="-1" aria-label="Current Issue" class="menu-item"><a href="/journals/lancet/issue/current" title="Current Issue"><span>Current Issue</span></a></li><li role="menuitem" tabindex="-1" aria-label="All Issues" class="menu-item"><a href="/journals/lancet/issues" title="All Issues"><span>All Issues</span></a></li><li role="menuitem" tabindex="-1" aria-label="Special Issues" class="menu-item"><a href="/journals/lancet/specialIssue" title="Special Issues"><span>Special Issues</span></a></li><li role="menuitem" tabindex="-1" aria-label="About the journal" class="menu-item"><a href="/lancet/about" title="About the journal"><span>About the journal</span></a></li></ul></li><li role="menuitem" aria-haspopup="true" aria-label="Journals" id="menu-item-main-menu-1" class="dropdown menu-parent"><a href="#" title="Journals" id="main-menu-1" data-toggle="dropdown" class="dropdown__toggle"><span>Journals</span><i aria-hidden="true" class="icon-arrow_r pull-right"></i></a><ul id="menu-items-1" role="menu" class="rlist dropdown__menu level-2"><li role="menuitem" aria-haspopup="true" class="menu-drawer__back hidden-md hidden-lg"><a href="#" class="menu-drawer__back__ctrl"><i aria-hidden="true" class="icon-arrow_l"></i><span>Back</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet" class="menu-item"><a href="/journals/lancet/home" title="The Lancet"><span>The Lancet</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Child &amp; Adolescent Health" class="menu-item"><a href="/journals/lanchi/home" title="The Lancet Child &amp; Adolescent Health"><span>The Lancet Child & Adolescent Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Diabetes &amp; Endocrinology" class="menu-item"><a href="/journals/landia/home" title="The Lancet Diabetes &amp; Endocrinology"><span>The Lancet Diabetes & Endocrinology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Digital Health" class="menu-item"><a href="/journals/landig/home" title="The Lancet Digital Health"><span>The Lancet Digital Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Gastroenterology &amp;amp; Hepatology" class="menu-item"><a href="/journals/langas/home" title="The Lancet Gastroenterology &amp;amp; Hepatology"><span>The Lancet Gastroenterology &amp; Hepatology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Global Health" class="menu-item"><a href="/journals/langlo/home" title="The Lancet Global Health"><span>The Lancet Global Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Haematology" class="menu-item"><a href="/journals/lanhae/home" title="The Lancet Haematology"><span>The Lancet Haematology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet HIV" class="menu-item"><a href="/journals/lanhiv/home" title="The Lancet HIV"><span>The Lancet HIV</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Infectious Diseases" class="menu-item"><a href="/journals/laninf/home" title="The Lancet Infectious Diseases"><span>The Lancet Infectious Diseases</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Microbe" class="menu-item"><a href="/journals/lanmic/home" title="The Lancet Microbe"><span>The Lancet Microbe</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Neurology" class="menu-item"><a href="/journals/laneur/home" title="The Lancet Neurology"><span>The Lancet Neurology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Oncology" class="menu-item"><a href="/journals/lanonc/home" title="The Lancet Oncology"><span>The Lancet Oncology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Planetary Health" class="menu-item"><a href="/journals/lanplh/home" title="The Lancet Planetary Health"><span>The Lancet Planetary Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Psychiatry" class="menu-item"><a href="/journals/lanpsy/home" title="The Lancet Psychiatry"><span>The Lancet Psychiatry</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Public Health" class="menu-item"><a href="/journals/lanpub/home" title="The Lancet Public Health"><span>The Lancet Public Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Regional Health" class="menu-item"><a href="/regional-health" title="The Lancet Regional Health"><span>The Lancet Regional Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Respiratory Medicine" class="menu-item"><a href="/journals/lanres/home" title="The Lancet Respiratory Medicine"><span>The Lancet Respiratory Medicine</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Rheumatology" class="menu-item"><a href="/journals/lanrhe/home" title="The Lancet Rheumatology"><span>The Lancet Rheumatology</span></a></li><li role="menuitem" tabindex="-1" aria-label="EBioMedicine" class="menu-item"><a href="/journals/ebiom/home" title="EBioMedicine"><span>EBioMedicine</span></a></li><li role="menuitem" tabindex="-1" aria-label="EClinicalMedicine" class="menu-item"><a href="/journals/eclinm/home" title="EClinicalMedicine"><span>EClinicalMedicine</span></a></li></ul></li><li role="menuitem" aria-haspopup="true" aria-label="Clinical" id="menu-item-main-menu-2" class="dropdown menu-parent"><a href="#" title="Clinical" id="main-menu-2" data-toggle="dropdown" class="dropdown__toggle"><span>Clinical</span><i aria-hidden="true" class="icon-arrow_r pull-right"></i></a><ul id="menu-items-2" role="menu" class="rlist dropdown__menu level-3"><li role="menuitem" aria-haspopup="true" class="menu-drawer__back hidden-md hidden-lg"><a href="#" class="menu-drawer__back__ctrl"><i aria-hidden="true" class="icon-arrow_l"></i><span>Back</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Clinic" class="menu-item"><a href="/clinical/diseases" title="The Lancet Clinic"><span>The Lancet Clinic</span></a></li><li role="menuitem" tabindex="-1" aria-label="Series" class="menu-item"><a href="/clinical/series" title="Series"><span>Series</span></a></li><li role="menuitem" tabindex="-1" aria-label="Commissions" class="menu-item"><a href="/clinical/commissions" title="Commissions"><span>Commissions</span></a></li><li role="menuitem" tabindex="-1" aria-label="Picture Quiz" class="menu-item"><a href="/picture-quiz" title="Picture Quiz"><span>Picture Quiz</span></a></li></ul></li><li role="menuitem" aria-haspopup="true" aria-label="Global Health" id="menu-item-main-menu-3" class="dropdown menu-parent"><a href="#" title="Global Health" id="main-menu-3" data-toggle="dropdown" class="dropdown__toggle"><span>Global Health</span><i aria-hidden="true" class="icon-arrow_r pull-right"></i></a><ul id="menu-items-3" role="menu" class="rlist dropdown__menu level-4"><li role="menuitem" aria-haspopup="true" class="menu-drawer__back hidden-md hidden-lg"><a href="#" class="menu-drawer__back__ctrl"><i aria-hidden="true" class="icon-arrow_l"></i><span>Back</span></a></li><li role="menuitem" tabindex="-1" aria-label="Hub" class="menu-item"><a href="/global-health" title="Hub"><span>Hub</span></a></li><li role="menuitem" tabindex="-1" aria-label="Series" class="menu-item"><a href="/global-health/series" title="Series"><span>Series</span></a></li><li role="menuitem" tabindex="-1" aria-label="Commissions" class="menu-item"><a href="/global-health/commissions" title="Commissions"><span>Commissions</span></a></li><li role="menuitem" tabindex="-1" aria-label="Global Burden of Diseases" class="menu-item"><a href="/gbd" title="Global Burden of Diseases"><span>Global Burden of Diseases</span></a></li></ul></li><li role="menuitem" aria-haspopup="true" aria-label="Information" id="menu-item-main-menu-4" class="dropdown menu-parent"><a href="#" title="Information" id="main-menu-4" data-toggle="dropdown" class="dropdown__toggle"><span>Information</span><i aria-hidden="true" class="icon-arrow_r pull-right"></i></a><ul id="menu-items-4" role="menu" class="rlist dropdown__menu level-5"><li role="menuitem" aria-haspopup="true" class="menu-drawer__back hidden-md hidden-lg"><a href="#" class="menu-drawer__back__ctrl"><i aria-hidden="true" class="icon-arrow_l"></i><span>Back</span></a></li><li role="menuitem" tabindex="-1" aria-label="About" class="menu-item"><a href="/about-us" title="About"><span>About</span></a></li><li role="menuitem" tabindex="-1" aria-label="Authors" class="menu-item"><a href="/for-authors" title="Authors"><span>Authors</span></a></li><li role="menuitem" tabindex="-1" aria-label="Readers" class="menu-item"><a href="/access-to-content" title="Readers"><span>Readers</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet App" class="menu-item"><a href="/app" title="The Lancet App"><span>The Lancet App</span></a></li><li role="menuitem" tabindex="-1" aria-label="Advertisers" class="menu-item"><a href="/for-advertisers" title="Advertisers"><span>Advertisers</span></a></li><li role="menuitem" tabindex="-1" aria-label="Press" class="menu-item"><a href="/press-room" title="Press"><span>Press</span></a></li><li role="menuitem" tabindex="-1" aria-label="Careers" class="menu-item"><a href="http://careers.thelancet.com/home/" title="Careers"><span>Careers</span></a></li><li role="menuitem" tabindex="-1" aria-label="Conferences" class="menu-item"><a href="/conferences" title="Conferences"><span>Conferences</span></a></li></ul></li><li role="menuitem" aria-haspopup="true" aria-label="Submit a Paper" id="menu-item-main-menu-5" class="dropdown menu-parent"><a href="#" title="Submit a Paper" id="main-menu-5" data-toggle="dropdown" class="dropdown__toggle"><span>Submit a Paper</span><i aria-hidden="true" class="icon-arrow_r pull-right"></i></a><ul id="menu-items-5" role="menu" class="rlist dropdown__menu level-6"><li role="menuitem" aria-haspopup="true" class="menu-drawer__back hidden-md hidden-lg"><a href="#" class="menu-drawer__back__ctrl"><i aria-hidden="true" class="icon-arrow_l"></i><span>Back</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet" class="menu-item"><a href="/lancet/about" title="The Lancet"><span>The Lancet</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Child &amp; Adolescent Health" class="menu-item"><a href="/lanchi/about" title="The Lancet Child &amp; Adolescent Health"><span>The Lancet Child & Adolescent Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Diabetes &amp; Endocrinology" class="menu-item"><a href="/landia/about" title="The Lancet Diabetes &amp; Endocrinology"><span>The Lancet Diabetes & Endocrinology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Digital Health" class="menu-item"><a href="/landig/about" title="The Lancet Digital Health"><span>The Lancet Digital Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Gastroenterology &amp; Hepatology" class="menu-item"><a href="/langas/about" title="The Lancet Gastroenterology &amp; Hepatology"><span>The Lancet Gastroenterology & Hepatology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Global Health" class="menu-item"><a href="/langlo/about" title="The Lancet Global Health"><span>The Lancet Global Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Haematology" class="menu-item"><a href="/lanhae/about" title="The Lancet Haematology"><span>The Lancet Haematology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet HIV" class="menu-item"><a href="/lanhiv/about" title="The Lancet HIV"><span>The Lancet HIV</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Infectious Diseases" class="menu-item"><a href="/laninf/about" title="The Lancet Infectious Diseases"><span>The Lancet Infectious Diseases</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Microbe" class="menu-item"><a href="/lanmic/about" title="The Lancet Microbe"><span>The Lancet Microbe</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Neurology" class="menu-item"><a href="/laneur/about" title="The Lancet Neurology"><span>The Lancet Neurology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Oncology" class="menu-item"><a href="/lanonc/about" title="The Lancet Oncology"><span>The Lancet Oncology</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Planetary Health" class="menu-item"><a href="/lanplh/about" title="The Lancet Planetary Health"><span>The Lancet Planetary Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Psychiatry" class="menu-item"><a href="/lanpsy/about" title="The Lancet Psychiatry"><span>The Lancet Psychiatry</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Public Health" class="menu-item"><a href="/lanpub/about" title="The Lancet Public Health"><span>The Lancet Public Health</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Regional Health - Western Pacific" class="menu-item"><a href="/lanwpc/about" title="The Lancet Regional Health - Western Pacific"><span>The Lancet Regional Health - Western Pacific</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Respiratory Medicine" class="menu-item"><a href="/lanres/about" title="The Lancet Respiratory Medicine"><span>The Lancet Respiratory Medicine</span></a></li><li role="menuitem" tabindex="-1" aria-label="The Lancet Rheumatology" class="menu-item"><a href="/lanrhe/about" title="The Lancet Rheumatology"><span>The Lancet Rheumatology</span></a></li><li role="menuitem" tabindex="-1" aria-label="EBioMedicine" class="menu-item"><a href="/ebiom/about" title="EBioMedicine"><span>EBioMedicine</span></a></li><li role="menuitem" tabindex="-1" aria-label="EClinicalMedicine" class="menu-item"><a href="/eclinm/about" title="EClinicalMedicine"><span>EClinicalMedicine</span></a></li><li role="menuitem" tabindex="-1" aria-label="Preprints with The Lancet" class="menu-item"><a href="/preprints" title="Preprints with The Lancet"><span>Preprints with The Lancet</span></a></li></ul></li><li role="menuitem" aria-label="COVID-19 Resource Centre" id="menu-item-main-menu-6" class="menu-item"><a href="/coronavirus" title="COVID-19 Resource Centre"><span>COVID-19 Resource Centre</span></a></li><li role="menuitem" aria-label="The Lancet Home" id="menu-item-main-menu-7" class="menu-item"><a href="/home" title="The Lancet Home"><span>The Lancet Home</span></a></li></ul></nav></div><div class="header__dropzone"><div class="pb-dropzone" data-pb-dropzone="menuDropzone" title="menuDropzone"></div></div>

            

        

    

        


    

            

            

            <div data-widget-id="036d7208-4ae6-4144-a35d-6a83657fa8f9" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><a href="#" title="Search" data-db-target-for="quickSearch" aria-expanded="false" aria-controls="quick-search-holder" class="search-drawer"><i aria-hidden="true" class="icon-search"></i></a><div data-db-target-of="quickSearch" id="quick-search-holder" class="dropBlock__holder quick-search__holder"><div class="tab row clearfix quick-search__wrapper"><input type="hidden" name="autoCompleteUrl" value="https://search-autocomplete.elsevier-jbs.com/autocomplete/jsonp" class="autoCompleteServerURL"/><form action="https://www.thelancet.com/action/doSearch?journalCode=lancet" name="quickSearchBar" method="get" title="Quick Search" onSubmit="return validateQuickSearchForm();"><div class="clearfix"><div class="col-sm-5 col-md-6 col-lg-7"><input type="hidden" name="searchType" value="quick" aria-hidden="true"/><div class="input-group quick-search__searchbar"><input type="text" name="searchText" placeholder="Search for..." class="autoComplete"/></div><button type="submit" title="Search" aria-label="Search" class="btn quick-search__button icon-search"><span>Go search</span></button></div><div class="col-sm-4 col-md-4 col-lg-3"><select class="quick-search__dropdown"><option value="all" selected="selected">All Content</option><option value="articleTitleAbstractKeywords">Article Title, Abstract, Keywords</option><option value="author">Authors</option><option value="articleTitle">Article Title</option><option value="abstract">Abstract</option></select><div class="quick-search__scope-options clearfix"><label for="searchScopeSeries" title="This Journal"><span>This Journal</span><input id="searchScopeSeries" type="radio" name="searchScope" title="This Journal" value="series" checked="checked"/></label><label for="searchScopeFullSite" title="Full Site"><span>Full Site</span><input id="searchScopeFullSite" type="radio" name="searchScope" value="fullSite" title="Full Site"/></label><input type="hidden" name="journalCode" value="lancet" aria-hidden="true"/><input type="hidden" name="seriesISSNFltraddfilter" value="0140-6736" aria-hidden="true"/></div></div><input type="hidden" name="occurrences" value="all" aria-hidden="true"/><div class="col-sm-3 col-md-2 col-lg-2"><div class="quick-search__advanced-region"><a href="https://www.thelancet.com/search/advanced?searchType=advanced&amp;journalCode=lancet&amp;seriesIssn=0140-6736" title="Advanced search" class="quick-search__advanced-link">Advanced Search</a></div></div><input type="hidden" name="code" value="lancet-site" aria-hidden="true"/><input type="hidden" name="journalCode" value="lancet" aria-hidden="true"/></div></form><a href="#" title="Close search bar" class="quick-search__ctrl quick-search__close hidden-xs hidden-sm"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div></div></div>

            

        

    

        


    

            

            

            <ul data-widget-id="09747bb0-d356-41e4-8906-6599a06f29d5" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li><a href="/action/showLogin?redirectUri=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931180-6%2Ffulltext&amp;pii=S0140-6736%2820%2931180-6" title="Log in to Lancet.com">Log in</a></li><li class="profile-links__register"><a href="/action/registration?journalCode=lancet&amp;redirectUri=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2820%2931180-6%2Ffulltext" title="Register a username and password for free">Register</a></li><li class="profile-links__subscribe"><a href="/journals/lancet/subscribe" title="Subscribe to a Lancet journal">Subscribe</a></li><li class="profile-links__claim"><a href="/journals/lancet/activate" title="Claim your online subscription">Claim</a></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="bb5194fa-af01-4fe9-8c3b-ab27bff6c471">
                
                

                <div class="wrapped " >
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/S0140-6736(20)31180-6">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</div></div>

            

        
</header></div>

            

        










        <main data-widget-def="UX3articleContent" data-widget-id="613c3767-893e-4bf8-99cb-7afbffa7b9ed" class="content">
        
    

        


    

            

            

            <article data-widget-id="613c3767-893e-4bf8-99cb-7afbffa7b9ed" data-widget-name="UX3articleContent" data-pii="S0140-6736(20)31180-6"><div id="articleHeader" class="article__header"><div class="article-header"><div class="article-header__overlay"></div><div class="what-image__wrapper"><img data-src="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cbedc4e7-a79c-42d0-8b51-55e387baadef/gr1.gif" aria-hidden="true" class="what-image b-lazy"></img></div><div class="article-header__wrapper"><div class="article-header__top"><div class="row"><div class="col-md-6"><div class="article-header__meta"><span class="article-header__journal">Articles</span><span class="article-header__sep">|</span><a href="https://www.thelancet.com/journals/lancet/onlinefirst" class="article-header__vol faded">Online First</a><span></span><span class="article-header__date faded"></span></div></div><div class="col-md-6"><div class="article-header__dropZone pb-dropzone" data-pb-dropzone="articleTools-dropzone"><div data-widget-id="daeead20-90ca-40c7-9a88-59138e573056" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><div class="article-tools__wrapper"><span class="article-tools__header"><!--.transplant(data-target="article h1" data-remove="false" data-target-class="hidden-xs hidden-sm" data-toggle="transplant" data-transplant="content")--></span><div class="article-tools__holder pull-right"><ul class="rlist rlist--inline article-tools__list"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0140-6736%2820%2931180-6" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><i aria-hidden="true" class="icon-gizmo-pdf-file"></i><span class="basic">PDF [528 KB]</span><span class="alternative">Download PDF [528 KB]</span></a></li><li class="article-tools__item article-tools__figures"><div aria-hidden="true" class="dropBlock article-tools__dropblock article-tools__figures"><a href="#" title="open Figures menu" data-db-target-for="article-tools-figures" aria-expanded="false" class="article-tools__ctrl article-tools__item__figures"><i aria-hidden="true" class="icon-gizmo-image_figure"></i><span>Figures</span></a><div data-db-target-of="article-tools-figures" class="dropBlock__holder article-tools__dropblock__holder"><ul class="rlist article-tools__sub-list"><li class="article-tools__sub-item"><a href="#" title="Figure Viewer (opens in a new tab)" target="_blank" class="article-tools__item__displayFigureViewer js--openFigureViewer">Figure Viewer</a></li><li class="article-tools__sub-item"><a href="/journals/lancet/article/PIIS0140-6736(20)31180-6/ppt" title="Download Figures (PPT) (opens in a new tab)" target="_blank" class="article-tools__item__displayDownloadFigures">Download Figures (PPT)</a></li></ul></div></div></li><li class="article-tools__item article-tools__save"><div aria-hidden="false" class="dropBlock article-tools__dropblock article-tools__save"><a href="#" title="open Save menu" data-db-target-for="article-tools-save" aria-expanded="false" class="article-tools__ctrl article-tools__item__save"><i aria-hidden="true" class="icon-gizmo-folder-in"></i><span>Save</span></a><div data-db-target-of="article-tools-save" class="dropBlock__holder article-tools__dropblock__holder"><ul class="rlist article-tools__sub-list"><li class="article-tools__sub-item"><a href="#" title="Add To Online Library" class="article-tools__item__displayAddToOnlineLibrary mendeley">Add To Online Library</a><span class="powered-by"><span>Powered By</span><i class="icon-mendeley"></i><span>Mendeley</span></span></li><li class="article-tools__sub-item"><a href="https://www.thelancet.com/personalize/addFavoritePublication?doi=10.1016%2FS0140-6736%2820%2931180-6" title="Add To My Reading List (opens in a new tab)" target="_blank" class="article-tools__item__displayAddToMyReadingList">Add To My Reading List</a></li><li class="article-tools__sub-item"><a href="https://www.thelancet.com/action/showCitFormats?doi=10.1016%2FS0140-6736%2820%2931180-6&amp;pii=S0140-6736%2820%2931180-6" title="Export Citation (opens in a new tab)" target="_blank" class="article-tools__item__displayExportCitation">Export Citation</a></li><li class="article-tools__sub-item"><a href="https://www.thelancet.com/action/addCitationAlert?doi=10.1016%2FS0140-6736%2820%2931180-6" title="Create Citation Alert (opens in a new tab)" target="_blank" class="article-tools__item__displayCreateCitationAlert">Create Citation Alert</a></li></ul></div></div></li><li class="article-tools__item">
    

        


    

            

            

            <!-- Go to www.addthis.com/dashboard to customize your tools --><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div data-widget-id="0e608a79-d2e8-493e-a0b1-73ebdad146a2" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><a href="#" data-db-target-for="0e608a79-d2e8-493e-a0b1-73ebdad146a2" aria-expanded="false" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-gizmo-share"></i><span>Share</span></a><div data-db-target-of="0e608a79-d2e8-493e-a0b1-73ebdad146a2" id="0e608a79-d2e8-493e-a0b1-73ebdad146a2_Pop" class="share__block dropBlock__holder article-tools__dropblock__holder"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook3"></i><span>Facebook</span></a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter3"></i><span>Twitter</span></a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin3"></i><span>LinkedIn</span></a></li><li><a role="link" class="addthis_button_mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley"></i><span>Mendeley</span></a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email"></i><span>Email</span></a></li><li><a role="link" class="addthis_button_sinaweibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li></ul></div></div>

            

        
</li><li><div class="dropBlock article-tools__dropblock article-tools__more"><a href="#" title="Show more tools menu" data-db-target-for="article-tools-more" aria-expanded="false" class="article-tools__ctrl"><i aria-hidden="true" class="icon-dots-three-horizontal"></i><span>more</span></a><div data-db-target-of="article-tools-more" class="dropBlock__holder article-tools__dropblock__holder"><ul class="rlist"><li><a href="http://reprints.elsevier.com/index.php?option=com_oscommerce&amp;amp;osMod=raq&amp;amp;Itemid=7&amp;amp;publicationName=The Lancet&amp;amp;title=Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis&amp;amp;creator=Mandeep+R+Mehra+and+colleagues&amp;amp;volume=0&amp;amp;number=0&amp;amp;startingPage=&amp;amp;endingPage=" title="Reprints" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-gizmo-reprints"></i><span>Reprints</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0140673620311806&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Request" class="article-tools__item__request"><i aria-hidden="true" class="icon-copyright"></i><span>Request</span></a></li></ul></div></div></li><li><a href="#" class="back-to-top"><i aria-hidden="true" class="icon-arrow_u_p"></i><span>Top</span></a></li></ul></div></div></div></div></div></div></div><div class="article-header__middle"><h1 class="article-header__title">Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis</h1><span class="article-header__sub-title"></span><ul class="rlist loa inline-bullet-list " data-number-of-author="6"><li class="loa__item author"><div class="dropBlock article-header__info"><a href="#" data-db-target-for="au10-authorcard" aria-expanded="false" aria-controls="au10" class="loa__item__name article-header__info__ctrl loa__item__email" title="Correspondence information about the author Prof Mandeep R Mehra, MD ">Prof Mandeep R Mehra, MD <i aria-hidden="true" class="icon-gizmo-person faded"></i></a><div data-db-target-of="au10-authorcard" class="dropBlock__holder article-header__info__holder lefted"><div class="article-header__info__scrollable"><div class="article-header__info__label">Mandeep R Mehra</div><span class="article-header__info__group__label">Correspondence</span><div class="article-header__info__sub-label">Correspondence to: Prof Mandeep R Mehra, Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA 02115, USA</div><div class="article-header__info__body"><div class="article-header__info__social"><a class="article-header__info__email default" href="/cdn-cgi/l/email-protection#e48989818c9685a486938cca8c859692859680ca818091" title="Send email to Prof Mandeep R Mehra, MD "><i aria-hidden="true" class="icon-Email"></i><span>
                            Contact
                        </span></a></div><div class="article-header__info__group"><span class="article-header__info__group__label">Affiliations</span><div class="article-header__info__group__body">Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA, USA</div></div><a href="/action/doSearch?searchType=authorLookUp&amp;author=Mehra,&#xA;            Mandeep R&amp;prod=LN" class="author__search" target="_blank"><i class="icon-arrow_r"></i><span>Search for articles by this author</span></a></div></div><a href="#" title="Close info" class="dropBlock__ctrl--close"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><div class="dropBlock article-header__info"><a title="Send email to Mandeep R Mehra" class="loa__item__name  loa__item__email" href="/cdn-cgi/l/email-protection#4825252d203a29082a3f206620293a3e293a2c662d2c3d"><i aria-hidden="true" class="icon-Email faded"></i></a></div></li><li class="loa__item author"><div class="dropBlock article-header__info"><a href="#" data-db-target-for="au20-authorcard" aria-expanded="false" aria-controls="au20" class="loa__item__name article-header__info__ctrl loa__item__email" title="Correspondence information about the author Sapan S Desai, MD ">Sapan S Desai, MD </a><div data-db-target-of="au20-authorcard" class="dropBlock__holder article-header__info__holder lefted"><div class="article-header__info__scrollable"><div class="article-header__info__label">Sapan S Desai</div><div class="article-header__info__body"><div class="article-header__info__social"><ul class="rlist inline-bullet-list"></ul></div><div class="article-header__info__group"><span class="article-header__info__group__label">Affiliations</span><div class="article-header__info__group__body">Surgisphere Corporation, Chicago, IL, USA</div></div><a href="/action/doSearch?searchType=authorLookUp&amp;author=Desai,&#xA;            Sapan S&amp;prod=LN" class="author__search" target="_blank"><i class="icon-arrow_r"></i><span>Search for articles by this author</span></a></div></div><a href="#" title="Close info" class="dropBlock__ctrl--close"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div></li><li class="loa__item author"><div class="dropBlock article-header__info"><a href="#" data-db-target-for="au30-authorcard" aria-expanded="false" aria-controls="au30" class="loa__item__name article-header__info__ctrl loa__item__email" title="Correspondence information about the author Prof Frank Ruschitzka, MD ">Prof Frank Ruschitzka, MD </a><div data-db-target-of="au30-authorcard" class="dropBlock__holder article-header__info__holder lefted"><div class="article-header__info__scrollable"><div class="article-header__info__label">Frank Ruschitzka</div><div class="article-header__info__body"><div class="article-header__info__social"><ul class="rlist inline-bullet-list"></ul></div><div class="article-header__info__group"><span class="article-header__info__group__label">Affiliations</span><div class="article-header__info__group__body">University Heart Center, University Hospital Zurich, Zurich, Switzerland</div></div><a href="/action/doSearch?searchType=authorLookUp&amp;author=Ruschitzka,&#xA;            Frank&amp;prod=LN" class="author__search" target="_blank"><i class="icon-arrow_r"></i><span>Search for articles by this author</span></a></div></div><a href="#" title="Close info" class="dropBlock__ctrl--close"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div></li><li class="loa__item author"><div class="dropBlock article-header__info"><a href="#" data-db-target-for="au40-authorcard" aria-expanded="false" aria-controls="au40" class="loa__item__name article-header__info__ctrl loa__item__email" title="Correspondence information about the author Amit N Patel, MD ">Amit N Patel, MD </a><div data-db-target-of="au40-authorcard" class="dropBlock__holder article-header__info__holder lefted"><div class="article-header__info__scrollable"><div class="article-header__info__label">Amit N Patel</div><div class="article-header__info__body"><div class="article-header__info__social"><ul class="rlist inline-bullet-list"></ul></div><div class="article-header__info__group"><span class="article-header__info__group__label">Affiliations</span><div class="article-header__info__group__body">Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA<p></p>HCA Research Institute, Nashville, TN, USA</div></div><a href="/action/doSearch?searchType=authorLookUp&amp;author=Patel,&#xA;            Amit N&amp;prod=LN" class="author__search" target="_blank"><i class="icon-arrow_r"></i><span>Search for articles by this author</span></a></div></div><a href="#" title="Close info" class="dropBlock__ctrl--close"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div></li> </ul><div class="inline-it"><span class="article-header__publish-date bulleted"><span class="article-header__publish-date__label">Published:</span><span class="article-header__publish-date__value">May 22, 2020</span></span><span class="article-header__doi bulleted"><span class="article-header__doi__label">DOI:</span><a class="article-header__doi__value" href="https://doi.org/10.1016/S0140-6736(20)31180-6">https://doi.org/10.1016/S0140-6736(20)31180-6</a></span><span class="article-header__mark bulleted"><a id="open-crossmark" data-target="crossmark"><img id="crossmark-icon" width="150" src="//crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"></img></a><meta name="dc.identifier" scheme="doi" content="doi:10.1016/S0140-6736(20)31180-6"></meta></span></div></div><div class="article-header__bottom clearfix row"><div class="col-md-6 static-md"></div><div class="col-md-6 static-md"><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" src="//d39af2mgp1pqhg.cloudfront.net/widget-popup.js"></script><a href="https://plu.mx/plum/a/?doi=10.1016/S0140-6736(20)31180-6" class="plumx-plum-print-popup plum-jbs-theme article-header__metrics" data-popup="left" data-hide-when-empty="true" data-hide-usage="true" data-pass-hidden-categories="true" data-site="plum" data-badge="true" data-size="small">Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis</a></div></div></div><div class="article-header__dropZone pb-dropzone" data-pb-dropzone="articleNavigation-Dropzone"><div data-widget-id="45024cb7-3a38-4932-876d-1ddfe7426788" data-widget-name="UX3ArticleNavigation" class="content-navigation clearfix"><div class="content-navigation__btn__wrapper--prev"><a href="/journals/lancet/article/PIIS0140-6736(20)31208-3/fulltext" title="Previous Article" class="content-navigation__btn--pre default"><span class="content-navigation__body pre"><span class="content-navigation__body__top">Previous Article</span><span class="content-navigation__body__title">Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial</span></span><i aria-hidden="true" class="icon-arrow_l"></i></a></div><div class="content-navigation__extra"></div><div class="content-navigation__btn__wrapper--next"><a href="/journals/lancet/article/PIIS0140-6736(20)31174-0/fulltext" title="Next Article" class="content-navigation__btn--next default"><span class="content-navigation__body next"><span class="content-navigation__body__top">Next Article</span><span class="content-navigation__body__title">Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?</span></span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div><div class="article__body"><button title="open table of sections" aria-label="open table of sections" type="button" class="left-side-nav__ctrl"><i aria-hidden="true" class="icon-sub-menu"></i></button><div class="left-side-nav col-md-2 col-lg-1"><ul class="rlist left-side-nav__upper"></ul><ul class="rlist left-side-nav__bottom"></ul></div><div class="adplaceholders hidden-xs hidden-sm">
    

        


    

            

            

            <div data-widget-id="99e315f6-ba9f-411b-a345-4bd3b79d4800" data-widget-name="UX3HTMLWidget"><!--HubSpot Call-to-Action Code --><span class="hs-cta-wrapper" id="hs-cta-wrapper-79472462-b4ce-48bc-a460-7e5d92c4f21f"><span class="hs-cta-node hs-cta-79472462-b4ce-48bc-a460-7e5d92c4f21f" id="hs-cta-79472462-b4ce-48bc-a460-7e5d92c4f21f"><!--[if lte IE 8]><div id="hs-cta-ie-element"></div><![endif]--><a href="https://cta-redirect.hubspot.com/cta/redirect/3798016/79472462-b4ce-48bc-a460-7e5d92c4f21f"  target="_blank" ><img class="hs-cta-img" id="hs-cta-img-79472462-b4ce-48bc-a460-7e5d92c4f21f" style="border-width:0px;" src="https://no-cache.hubspot.com/cta/default/3798016/79472462-b4ce-48bc-a460-7e5d92c4f21f.png"  alt="Recommend this journal  to your librarian"/></a></span><script charset="utf-8" src="https://js.hscta.net/cta/current.js"></script><script type="text/javascript"> hbspt.cta.load(3798016, '79472462-b4ce-48bc-a460-7e5d92c4f21f', {}); </script></span><!-- end HubSpot Call-to-Action Code --></div>

            

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="c54c51f6-527b-4406-9aea-c93b1e1c1e66">
                
                

                <div class="wrapped " >
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement"/>
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <div class="gpt-ad disableStickySidebar" data-adsize="skyscraper"></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        


</div><div class="container"><div class="row"><div class="col-md-2 col-lg-1 hidden-sm"></div><div class="col-md-7 col-lg-9 article__sections"><section><h2 class="top" id="seccestitle10" data-left-hand-nav="Summary"><span class="top__sub"></span><span class="top__text">Summary</span></h2><div class="section-paragraph"><h3>Background</h3><div class="section-paragraph">Hydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19, despite no conclusive evidence of their benefit. Although generally safe when used for approved indications such as autoimmune disease or malaria, the safety and benefit of these treatment regimens are poorly evaluated in COVID-19.</div><h3>Methods</h3><div class="section-paragraph">We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. The registry comprised data from 671 hospitals in six continents. We included patients hospitalised between Dec 20, 2019, and April 14, 2020, with a positive laboratory finding for SARS-CoV-2. Patients who received one of the treatments of interest within 48 h of diagnosis were included in one of four treatment groups (chloroquine alone, chloroquine with a macrolide, hydroxychloroquine alone, or hydroxychloroquine with a macrolide), and patients who received none of these treatments formed the control group. Patients for whom one of the treatments of interest was initiated more than 48 h after diagnosis or while they were on mechanical ventilation, as well as patients who received remdesivir, were excluded. The main outcomes of interest were in-hospital mortality and the occurrence of de-novo ventricular arrhythmias (non-sustained or sustained ventricular tachycardia or ventricular fibrillation).</div><h3>Findings</h3><div class="section-paragraph">96 032 patients (mean age 53·8 years, 46·3% women) with COVID-19 were hospitalised during the study period and met the inclusion criteria. Of these, 14 888 patients were in the treatment groups (1868 received chloroquine, 3783 received chloroquine with a macrolide, 3016 received hydroxychloroquine, and 6221 received hydroxychloroquine with a macrolide) and 81 144 patients were in the control group. 10 698 (11·1%) patients died in hospital. After controlling for multiple confounding factors (age, sex, race or ethnicity, body-mass index, underlying cardiovascular disease and its risk factors, diabetes, underlying lung disease, smoking, immunosuppressed condition, and baseline disease severity), when compared with mortality in the control group (9·3%), hydroxychloroquine (18·0%; hazard ratio 1·335, 95% CI 1·223–1·457), hydroxychloroquine with a macrolide (23·8%; 1·447, 1·368–1·531), chloroquine (16·4%; 1·365, 1·218–1·531), and chloroquine with a macrolide (22·2%; 1·368, 1·273–1·469) were each independently associated with an increased risk of in-hospital mortality. Compared with the control group (0·3%), hydroxychloroquine (6·1%; 2·369, 1·935–2·900), hydroxychloroquine with a macrolide (8·1%; 5·106, 4·106–5·983), chloroquine (4·3%; 3·561, 2·760–4·596), and chloroquine with a macrolide (6·5%; 4·011, 3·344–4·812) were independently associated with an increased risk of de-novo ventricular arrhythmia during hospitalisation.</div><h3>Interpretation</h3><div class="section-paragraph">We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.</div><h3>Funding</h3><div class="section-paragraph">William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women's Hospital.</div></div></section><div data-pb-dropzone="relatedItems-dropzone" class="relatedItems-dropzone pb-dropzone"><div data-widget-id="6211e606-91ef-4fed-96eb-a6bff90d54e7" data-widget-name="UX3HTMLWidget"><div id="related-links-container"></div></div></div><section id="cesec10" data-locator="cesec10"><h2 class="top" id="seccestitle70" data-left-hand-nav="Introduction"><span class="top__sub"></span><span class="top__text">Introduction</span></h2><div class="section-paragraph">The absence of an effective treatment against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has led clinicians to redirect drugs that are known to be effective for other medical conditions to the treatment of COVID-19. Key among these repurposed therapeutic agents are the antimalarial drug chloroquine and its analogue hydroxychloroquine, which is used for the treatment of autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis.<div class="dropBlock reference-citations"><sup><a href="#" id="back-bib1" data-db-target-for="bib1-d12235461e1160" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib1">1</a></sup><div data-db-target-of="bib1-d12235461e1160" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Principi N </li><li class="loa__item">Esposito S </li></ul><div class="reference-citations__detials">Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.<div class="popup-ref"><span class="ref__series"><i>Lancet Infect Dis.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 17.</span>)</span><div class="citation-host"><a href="https://doi.org/10.1016/S1473-3099(20)30296-6" target="_blank">https://doi.org/10.1016/S1473-3099(20)30296-6</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Lancet+Infect+Dis&author=Principi+N&author=Esposito+S&title=Chloroquine+or+hydroxychloroquine+for+prophylaxis+of+COVID-19">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><sup>, </sup> <div class="dropBlock reference-citations"><sup><a href="#" id="back-bib2" data-db-target-for="bib2-d12235461e1160" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib2">2</a></sup><div data-db-target-of="bib2-d12235461e1160" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Perricone C </li><li class="loa__item">Triggianese P </li><li class="loa__item">Bartoloni E </li><li>et al.</li></ul><div class="reference-citations__detials">The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19.<div class="popup-ref"><span class="ref__series"><i>J Autoimmun.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 17.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.jaut.2020.102468" target="_blank">DOI:10.1016/j.jaut.2020.102468</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=J+Autoimmun&author=Perricone+C&author=Triggianese+P&author=Bartoloni+E&title=The+anti-viral+facet+of+anti-rheumatic+drugs%3A+lessons+from+COVID-19">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> These drugs have been shown in laboratory conditions to have antiviral properties as well as immunomodulatory effects.<div class="dropBlock reference-citations"><sup><a href="#" id="back-bib3" data-db-target-for="bib3-d12235461e1164" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib3">3</a></sup><div data-db-target-of="bib3-d12235461e1164" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Liu J </li><li class="loa__item">Cao R </li><li class="loa__item">Xu M </li><li>et al.</li></ul><div class="reference-citations__detials">Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.<div class="popup-ref"><span class="ref__series"><i>Cell Discov.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">6</span></span>: <span class="ref__seriesPages">16</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=16&journal=Cell+Discov&author=Liu+J&author=Cao+R&author=Xu+M&title=Hydroxychloroquine%2C+a+less+toxic+derivative+of+chloroquine%2C+is+effective+in+inhibiting+SARS-CoV-2+infection+in+vitro">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><sup>, </sup> <div class="dropBlock reference-citations"><sup><a href="#" id="back-bib4" data-db-target-for="bib4-d12235461e1164" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib4">4</a></sup><div data-db-target-of="bib4-d12235461e1164" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Devaux CA </li><li class="loa__item">Rolain JM </li><li class="loa__item">Colson P </li><li class="loa__item">Raoult D </li></ul><div class="reference-citations__detials">New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?.<div class="popup-ref"><span class="ref__series"><i>Int J Antimicrob Agents.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 12.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.ijantimicag.2020.105938" target="_blank">DOI:10.1016/j.ijantimicag.2020.105938</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Int+J+Antimicrob+Agents&author=Devaux+CA&author=Rolain+JM&author=Colson+P&author=Raoult+D&title=New+insights+on+the+antiviral+effects+of+chloroquine+against+coronavirus%3A+what+to+expect+for+COVID-19%3F">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> However, the use of this class of drugs for COVID-19 is based on a small number of anecdotal experiences that have shown variable responses in uncontrolled observational analyses, and small, open-label, randomised trials that have largely been inconclusive.<div class="dropBlock reference-citations"><sup><a href="#" id="back-bib5" data-db-target-for="bib5-d12235461e1168" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib5">5</a></sup><div data-db-target-of="bib5-d12235461e1168" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Tang W </li><li class="loa__item">Cao Z </li><li class="loa__item">Han M </li><li>et al.</li></ul><div class="reference-citations__detials">Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial.<div class="popup-ref"><span class="ref__series"><i>medRxiv.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 7.</span>) <span class="refComment">(preprint).</span></span><div class="citation-host"><a href="http://dx.doi.org/10.1101/2020.04.10.20060558" target="_blank">DOI: 10.1101/2020.04.10.20060558</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=medRxiv&author=Tang+W&author=Cao+Z&author=Han+M&title=Hydroxychloroquine+in+patients+mainly+with+mild+to+moderate+COVID-19%3A+an+open-label%2C+randomized%2C+controlled+trial">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><sup>, </sup> <div class="dropBlock reference-citations"><sup><a href="#" id="back-bib6" data-db-target-for="bib6-d12235461e1168" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib6">6</a></sup><div data-db-target-of="bib6-d12235461e1168" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Chen J </li><li class="loa__item">Liu D </li><li class="loa__item">Liu L </li><li>et al.</li></ul><div class="reference-citations__detials">A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19.<div class="popup-ref"><span class="ref__series"><i>J Zhejiang Univ (Med Sci).</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">49</span></span>: <span class="ref__seriesPages">215-219</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2020&pages=215-219&journal=J+Zhejiang+Univ+%28Med+Sci%29&author=Chen+J&author=Liu+D&author=Liu+L&title=A+pilot+study+of+hydroxychloroquine+in+treatment+of+patients+with+moderate+COVID-19">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> The combination of hydroxychloroquine with a second-generation macrolide, such as azithromycin (or clarithromycin), has also been advocated, despite limited evidence for its effectiveness.<div class="dropBlock reference-citations"><sup><a href="#bib7" id="back-bib7" data-db-target-for="bib7-d12235461e1172" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib7">7</a></sup><div data-db-target-of="bib7-d12235461e1172" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Gautret P </li><li class="loa__item">Lagier JC </li><li class="loa__item">Parola P </li><li>et al.</li></ul><div class="reference-citations__detials">Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.<div class="popup-ref"><span class="ref__series"><i>Int J Antimicrob Agents.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 20.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.ijantimicag.2020.105949" target="_blank">DOI:10.1016/j.ijantimicag.2020.105949</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Int+J+Antimicrob+Agents&author=Gautret+P&author=Lagier+JC&author=Parola+P&title=Hydroxychloroquine+and+azithromycin+as+a+treatment+of+COVID-19%3A+results+of+an+open-label+non-randomized+clinical+trial">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Previous studies have shown that treatment with chloroquine, hydroxychloroquine, or either drug combined with a macrolide can have the cardiovascular adverse effect of prolongation of the QT interval, which could be a mechanism that predisposes to ventricular arrhythmias.<div class="dropBlock reference-citations"><sup><a href="#" id="back-bib8" data-db-target-for="bib8-d12235461e1176" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib8">8</a></sup><div data-db-target-of="bib8-d12235461e1176" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Ray WA </li><li class="loa__item">Murray KT </li><li class="loa__item">Hall K </li><li class="loa__item">Arbogast PG </li><li class="loa__item">Stein CM </li></ul><div class="reference-citations__detials">Azithromycin and the risk of cardiovascular death.<div class="popup-ref"><span class="ref__series"><i>N Engl J Med.</i> <span class="ref__seriesDate">2012; </span><span class="ref__seriesVolume">366</span></span>: <span class="ref__seriesPages">1881-1890</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=1881-1890&journal=N+Engl+J+Med&author=Ray+WA&author=Murray+KT&author=Hall+K&author=Arbogast+PG&author=Stein+CM&title=Azithromycin+and+the+risk+of+cardiovascular+death">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><sup>, </sup> <div class="dropBlock reference-citations"><sup><a href="#" id="back-bib9" data-db-target-for="bib9-d12235461e1176" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib9">9</a></sup><div data-db-target-of="bib9-d12235461e1176" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Giudicessi JR </li><li class="loa__item">Noseworthy PA </li><li class="loa__item">Friedman PA </li><li class="loa__item">Ackerman MJ </li></ul><div class="reference-citations__detials">Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19).<div class="popup-ref"><span class="ref__series"><i>Mayo Clin Proc.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 7.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.mayocp.2020.03.024" target="_blank">DOI:10.1016/j.mayocp.2020.03.024</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Mayo+Clin+Proc&author=Giudicessi+JR&author=Noseworthy+PA&author=Friedman+PA&author=Ackerman+MJ&title=Urgent+guidance+for+navigating+and+circumventing+the+QTc-prolonging+and+torsadogenic+potential+of+possible+pharmacotherapies+for+coronavirus+disease+19+%28COVID-19%29">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div></div><div class="section-paragraph"><div class="accordion--textbox"><div id="cetextbox10" class="accordion"><a href="#" aria-expanded="false" class="accordion__control" aria-controls="cetextbox10"><span></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><div class="accordion__content"><b>Research in context</b><div class="section-paragraph"><strong>Evidence before this study</strong></div><div class="section-paragraph">We searched MEDLINE (via PubMed) for articles published up to April 21, 2020, using the key words “novel coronavirus”, “2019-nCoV”, “COVID-19”, “SARS-CoV-2”, “therapy”, “hydroxychloroquine”, “chloroquine”, and “macrolide”. Moreover, we screened preprint servers, such as Medrxiv, for relevant articles and consulted the web pages of organisations such as the US National Institutes of Health and WHO. Hydroxychloroquine and chloroquine (used with or without a macrolide) are widely advocated for treatment of COVID-19 based on in-vitro evidence of an antiviral effect against severe acute respiratory syndrome coronavirus 2. Their use is based on small uncontrolled studies and in the absence of evidence from randomised controlled trials. Concerns have been raised that these drugs or their combination with macrolides could result in electrical instability and predispose patients to ventricular arrhythmias. Whether these drugs improve outcomes or are associated with harm in COVID-19 remains unknown.</div><div class="section-paragraph"><strong>Added value of this study</strong></div><div class="section-paragraph">In the absence of reported randomised trials, there is an urgent need to evaluate real-world evidence related to outcomes with the use of hydroxychloroquine or chloroquine (used with or without macrolides) in COVID-19. Using an international, observational registry across six continents, we assessed 96 032 patients with COVID-19, of whom 14 888 were treated with hydroxychloroquine, chloroquine, or their combination with a macrolide. After controlling for age, sex, race or ethnicity, underlying comorbidities, and disease severity at baseline, the use of all four regimens was associated with an increased hazard for de-novo ventricular arrythmia and death in hospital. This study provides real-world evidence on the use of these therapeutic regimens by including a large number of patients from across the world. Thus, to our knowledge, these findings provide the most comprehensive evidence of the use of hydroxychloroquine and chloroquine (with or without a macrolide) for treatment of COVID-19.</div><div class="section-paragraph"><strong>Implications of all the available evidence</strong></div><div class="section-paragraph">We found no evidence of benefit of hydroxychloroquine or chloroquine when used either alone or with a macrolide. Previous evidence was derived from either small anecdotal studies or inconclusive small randomised trials. Our study included a large number of patients across multiple geographic regions and provides the most robust real-world evidence to date on the usefulness of these treatment regimens. Although observational studies cannot fully account for unmeasured confounding factors, our findings suggest not only an absence of therapeutic benefit but also potential harm with the use of hydroxychloroquine or chloroquine drug regimens (with or without a macrolide) in hospitalised patients with COVID-19.</div></div></div></div></div><div class="section-paragraph">Although several multicentre randomised controlled trials are underway, there is a pressing need to provide accurate clinical guidance because the use of chloroquine or hydroxychloroquine along with macrolides is widespread, often with little regard for potential risk. Some countries have stockpiled these drugs, resulting in a shortage of these medications for those that need them for approved clinical indications.<div class="dropBlock reference-citations"><sup><a href="#bib10" id="back-bib10" data-db-target-for="bib10-d12235461e1204" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib10">10</a></sup><div data-db-target-of="bib10-d12235461e1204" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Peschken CA </li></ul><div class="reference-citations__detials">Possible consequences of a shortage of hydroxychloroquine for patients with systemic lupus erythematosus amid the COVID-19 pandemic.<div class="popup-ref"><span class="ref__series"><i>J Rheumatol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 8.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.3899/jrheum.200395" target="_blank">DOI:10.3899/jrheum.200395</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=J+Rheumatol&author=Peschken+CA&title=Possible+consequences+of+a+shortage+of+hydroxychloroquine+for+patients+with+systemic+lupus+erythematosus+amid+the+COVID-19+pandemic">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> The purpose of this study was to evaluate the use of chloroquine or hydroxychloroquine alone or in combination with a macrolide for treatment of COVID-19 using a large multinational registry to assess their real-world application. Principally, we sought to analyse the association between these treatment regimens and in-hospital death. Secondarily, we aimed to evaluate the occurrence of de-novo clinically significant ventricular arrhythmias.</div></section><section id="cesec20" data-locator="cesec20"><h2 class="top" id="seccestitle80" data-left-hand-nav="Methods"><span class="top__sub"></span><span class="top__text">Methods</span></h2><section id="cesec30" data-locator="cesec30"><h3 class="sectionTitle"><span class="top__sub"> </span><span class="top__text">Registry features and data acquisition</span></h3><div class="section-paragraph">We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. The registry comprised 671 hospitals located in six continents (<a href="#sec1" class="scroll-into-link">appendix p 3</a>). The Surgical Outcomes Collaborative (Surgisphere Corporation, Chicago, IL, USA) consists of de-identified data obtained by automated data extraction from inpatient and outpatient electronic health records, supply chain databases, and financial records. The registry uses a cloud-based health-care data analytics platform that includes specific modules for data acquisition, data warehousing, data analytics, and data reporting. A manual data entry process is used for quality assurance and validation to ensure that key missing values are kept to a minimum. The Surgical Outcomes Collaborative (hereafter referred to as the Collaborative) ensures compliance with the US Food and Drug Administration (FDA) guidance on real-world evidence. Real-world data are collected through automated data transfers that capture 100% of the data from each health-care entity at regular, predetermined intervals, thus reducing the impact of selection bias and missing values, and ensuring that the data are current, reliable, and relevant. Verifiable source documentation for the elements include electronic inpatient and outpatient medical records and, in accordance with the FDA guidance on relevance of real-world data, data acquisition is performed through use of a standardised Health Level Seven-compliant data dictionary, with data collected on a prospective ongoing basis. The validation procedure for the registry refers to the standard operating procedures in place for each of the four ISO 9001:2015 and ISO 27001:2013 certified features of the registry: data acquisition, data warehousing, data analytics, and data reporting.</div><div class="section-paragraph">The standardised Health Level Seven-compliant data dictionary used by the Collaborative serves as the focal point for all data acquisition and warehousing. Once this data dictionary is harmonised with electronic health record data, data acquisition is completed using automated interfaces to expedite data transfer and improve data integrity. Collection of a 100% sample from each health-care entity is validated against financial records and external databases to minimise selection bias. To reduce the risk of inadvertent protected health information disclosures, all such information is stripped before storage in the cloud-based data warehouse. The Collaborative is intended to minimise the effects of information bias and selection bias by capturing all-comer data and consecutive patient enrolment by capturing 100% of the data within electronic systems, ensuring that the results remain generalisable to the larger population. The Collaborative is compliant with the US Agency for Healthcare Research and Quality guidelines for registries. With the onset of the COVID-19 crisis, this registry was used to collect data from hospitals in the USA (that are selected to match the epidemiological characteristics of the US population) and internationally, to achieve representation from diverse populations across six continents. Data have been collected from a variety of urban and rural hospitals, academic or community hospitals, and for-profit and non-profit hospitals. The data collection and analyses are deemed exempt from ethics review.</div></section><section id="cesec40" data-locator="cesec40"><h3 class="sectionTitle"><span class="top__sub"> </span><span class="top__text">Study design</span></h3><div class="section-paragraph">We included all patients hospitalised between Dec 20, 2019, and April 14, 2020, at hospitals participating in the registry and with PCR-confirmed COVID-19 infection, for whom a clinical outcome of either hospital discharge or death during hospitalisation was recorded. A positive laboratory finding for SARS-CoV-2 was defined as a positive result on high-throughput sequencing or reverse transcription-quantitative PCR assay of nasal or pharyngeal swab specimens, and this finding was used for classifying a patient as positive for COVID-19. COVID-19 was diagnosed, at each site, on the basis of WHO guidance.<div class="dropBlock reference-citations"><sup><a href="#bib11" id="back-bib11" data-db-target-for="bib11-d12235461e1226" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib11">11</a></sup><div data-db-target-of="bib11-d12235461e1226" class="dropBlock__holder"><div class="dropBlock__body"><div class="reference-citations__detials"><span>WHO</span><br />Clinical management of severe acute respiratory infection (SARI) when novel COVID-19 disease is suspected: interim guidance.<div class="popup-ref"><div class="citation-host"><a href="https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf" target="_blank">https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf</a><div><span>Date: </span>March 13, 2020</div><div><span>Date accessed: </span>April 24, 2020</div></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=March+13%2C+2020&author=WHO&title=Clinical+management+of+severe+acute+respiratory+infection+%28SARI%29+when+novel+COVID-19+disease+is+suspected%3A+interim+guidance">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Patients who did not have a record of testing in the database, or who had a negative test, were not included in the study. Only one positive test was necessary for the patient to be included in the analysis. Patients who received either hydroxychloroquine or a chloroquine analogue-based treatment (with or without a second-generation macrolide) were included in the treatment group. Patients who received treatment with these regimens starting more than 48 h after COVID-19 diagnosis were excluded. We also excluded data from patients for whom treatment was initiated while they were on mechanical ventilation or if they were receiving therapy with the antiviral remdesivir. These specific exclusion criteria were established to avoid enrolment of patients in whom the treatment might have started at non-uniform times during the course of their COVID-19 illness and to exclude individuals for whom the drug regimen might have been used during a critical phase of illness, which could skew the interpretation of the results. Thus, we defined four distinct treatment groups, in which all patients started therapy within 48 h of an established COVID-19 diagnosis: chloroquine alone, chloroquine with a macrolide, hydroxychloroquine alone, or hydroxychloroquine with a macrolide. All other included patients served as the control population.</div></section><section id="cesec50" data-locator="cesec50"><h3 class="sectionTitle"><span class="top__sub"> </span><span class="top__text">Data collection</span></h3><div class="section-paragraph">Patient demographics, including age, body-mass index (BMI), sex, race or ethnicity, and continent of origin were obtained. Underlying comorbidities (based on International Classification of Diseases, tenth revision, clinical modification codes) present in either the inpatient or outpatient electronic health record were collected, which included cardiovascular disease (including coronary artery disease, congestive heart failure, and history of a cardiac arrhythmia), current or previous history of smoking, history of hypertension, diabetes, hyperlipidaemia, or chronic obstructive pulmonary disease (COPD), and presence of an immunosuppressed condition (steroid use, pre-existing immunological condition, or current chemotherapy in individuals with cancer). We collected data on use of medications at baseline, including cardiac medications (angiotensin converting enzyme [ACE] inhibitors, angiotensin receptor blockers, and statins) or use of antiviral therapy other than the drug regimens being evaluated. The initiation of hydroxychloroquine or chloroquine during hospital admission was recorded, including the time of initiation. The use of second-generation macrolides, specifically azithromycin and clarithromycin, was similarly recorded. A quick sepsis-related organ failure assessment (qSOFA) was calculated for the start of therapy (including a scored calculation of the mental status, respiratory rate, and systolic blood pressure) and oxygen saturation (SPO<sub>2</sub>) on room air was recorded, as measures of disease severity.</div></section><section id="cesec60" data-locator="cesec60"><h3 class="sectionTitle"><span class="top__sub"> </span><span class="top__text">Outcomes</span></h3><div class="section-paragraph">The primary outcome of interest was the association between use of a treatment regimen containing chloroquine or hydroxychloroquine (with or without a second-generation macrolide) when initiated early after COVID-19 diagnosis with the endpoint of in-hospital mortality. The secondary outcome of interest was the association between these treatment regimens and the occurrence of clinically significant ventricular arrhythmias (defined as the first occurrence of a non-sustained [at least 6 sec] or sustained ventricular tachycardia or ventricular fibrillation) during hospitalisation. We also analysed the rates of progression to mechanical ventilation use and the total and intensive care unit lengths of stay (in days) for patients in each group.</div></section><section id="cesec70" data-locator="cesec70"><h3 class="sectionTitle"><span class="top__sub"> </span><span class="top__text">Statistical analysis</span></h3><div class="section-paragraph">For the primary analysis of in-hospital mortality, we controlled for confounding factors, including demographic variables, comorbidities, disease severity at presentation, and other medication use (cardiac medications and other antiviral therapies). Categorical variables are shown as frequencies and percentages, and continuous variables as means with SDs. Comparison of continuous data between groups was done using the unpaired <em>t</em>-test and categorical data were compared using Fisher's exact test. A p value of less than 0·05 was considered significant. Multiple imputation for missing values was not possible because for disease and drug variables, there were no codes to indicate that data were missing; if the patient's electronic health record did not include information on a clinical characteristic, it was assumed that the characteristic was not present.</div><div class="section-paragraph">Cox proportional hazards regression analysis was done to evaluate the effect of age, sex, race or ethnicity (using white race as a reference group), comorbidities (BMI, presence of coronary artery disease, presence of congestive heart failure, history of cardiac arrhythmia, diabetes, or COPD, current smoker, history of hypertension, immunocompromised state, and history of hyperlipidaemia), medications (cardiac medications, antivirals, and the treatment regimens of interest), and severity of illness scores (qSOFA &lt;1 and SPO<sub>2</sub> &lt;94%) on the risk of clinically significant ventricular arrhythmia (using the time from admission to first occurrence, or if the event did not occur, to the time of discharge) and mortality (using the time from admission to inpatient mortality or discharge). Age and BMI were treated as continuous variables and all other data were treated as categorical variables in the model. From the model, hazard ratios (HRs) with 95% CIs were estimated for included variables to determine their effect on the risk of in-hospital mortality (primary endpoint) or subsequent mechanical ventilation or death (composite endpoint). Independence of survival times (or time to first arrhythmia for the ventricular arrhythmia analysis) was confirmed. Proportionality between the predictors and the hazard was validated through an evaluation of Schoenfeld residuals, which found p&gt;0·05 and thus confirmed proportionality.</div><div class="section-paragraph">To minimise the effect of confounding factors, a propensity score matching analysis was done individually for each of the four treatment groups compared with a control group that received no form of that therapy. For each treatment group, a separate matched control was identified using exact and propensity-score matched criteria with a calliper of 0·001. This method was used to provide a close approximation of demographics, comorbidities, disease severity, and baseline medications between patients. The propensity score was based on the following variables: age, BMI, gender, race or ethnicity, comorbidities, use of ACE inhibitors, use of statins, use of angiotensin receptor blockers, treatment with other antivirals, qSOFA score of less than 1, and SPO<sub>2</sub> of less than 94% on room air. The patients were well matched, with standardised mean difference estimates of less than 10% for all matched parameters.</div><div class="section-paragraph">Additional analyses were done to examine the robustness of the estimates initially obtained. Individual analyses by continent of origin and sex-adjusted analyses using Cox proportional hazards models were performed. A tipping-point analysis (an analysis that shows the effect size and prevalence of an unmeasured confounder that could shift the upper boundary of the CI towards null) was also done. All statistical analyses were done with R version 3.6.3 and SPSS version 26.</div></section><section id="cesec80" data-locator="cesec80"><h3 class="sectionTitle"><span class="top__sub"> </span><span class="top__text">Role of the funding source</span></h3><div class="section-paragraph">The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author and co-author ANP had full access to all the data in the study and had final responsibility for the decision to submit for publication.</div></section></section><section id="cesec90" data-locator="cesec90"><h2 class="top" id="seccestitle150" data-left-hand-nav="Results"><span class="top__sub"></span><span class="top__text">Results</span></h2><div class="section-paragraph">96 032 hospitalised patients from 671 hospitals were diagnosed with COVID-19 between Dec 20, 2019, and April 14, 2020 and met the inclusion criteria for this study (<a data-link="modal" data-target="#image-S0140-6736(20)31180-6gr1" href="#fig1" data-locator="fig1" id="back-gr1" class="figure-link scroll-into-link">figure 1</a>). All included patients completed their hospital course (discharged or died) by April 21, 2020. Patients who were hospitalised during the study period without a completed course were unable to be analysed. The study cohort included 63 315 (65·9%) patients from North America, 16 574 (17·3%) from Europe, 7555 (7·9%) from Asia, 4402 (4·6%) from Africa, 3577 (3·7%) from South America, and 609 (0·6%) from Australia (details of the number of hospitals per continent are presented in the <a href="#sec1" class="scroll-into-link">appendix, p 3</a>). The mean age was 53·8 years (SD 17·6), 44 426 (46·3%) were women, mean BMI was 27·6 kg/m<sup>2</sup> (SD 5·5; 29 510 [30·7%] were obese with BMI ≥30 kg/m<sup>2</sup>), 64 220 (66·9%) were white, 9054 (9·4%) were black, 5978 (6·2%) were Hispanic, and 13 519 (14·1%) were of Asian origin (<a href="#sec1" class="scroll-into-link">appendix p 4</a>). In terms of comorbidities, 30 198 (31·4%) had hyperlipidaemia, 25 810 (26·9%) had hypertension, 13 260 (13·8%) had diabetes, 3177 (3·3%) had COPD, 2868 (3·0%) had an underlying immunosuppressed condition, 16 553 (17·2%) were former smokers, and 9488 (9·9%) were current smokers. In terms of pre-existing cardiovascular disease, 12 137 (12·6%) had coronary artery disease, 2368 (2·5%) had a history of congestive heart failure, and 3381 (3·5%) had a history of arrhythmia. The mean length of stay in hospital was 9·1 days (SD 6·4), with an overall in-hospital mortality of 10 698 (11·1%) of 96 032. The use of other antivirals was recorded in 38 927 (40·5%) patients as treatment for COVID-19. The most common antivirals were lopinavir with ritonavir (12 304 [31·6%]), ribavirin (7904 [20·3%]), and oseltamivir (5101 [13·1%]). Combination therapy with more than one of these antiviral regimens was used for 6782 (17·4%) patients.<div class="floatDisplay"><figure id="fig1" class=""><img class="b-lazy" data-src="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cbedc4e7-a79c-42d0-8b51-55e387baadef/gr1.gif" alt="Figure thumbnail gr1" data-locator="fig1" data-high-res="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b8d6096f-e10d-4e2b-b93d-fc7a3ef19760/gr1_lrg.gif" data-large-image="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cbedc4e7-a79c-42d0-8b51-55e387baadef/gr1.gif"></img><figcaption><div class="figure__caption__body"><div class="figure__title"><span data-fv-label="Fig. 1" class="label figure__label">Figure 1</span><span class="figure__title__text">Study profile</span></div><ul class="rlist--inline separator download-links"><li><a target="_blank" href="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cbedc4e7-a79c-42d0-8b51-55e387baadef/gr1.gif" title="View Large Image in a new tab">View Large
                                            Image
                                        </a></li><li class="download-links__figureViewer"><a href="#" class="figure__open__ctrl">Figure Viewer</a></li><li><a href="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b8d6096f-e10d-4e2b-b93d-fc7a3ef19760/gr1_lrg.gif" class="download-links__download-Hi-res" target="_blank" download="">Download Hi-res
                                            image
                                        </a></li><li class="hidden-xs"><a href="/action/downloadFigures?pii=S0140-6736(20)31180-6&amp;id=gr1.gif" class="download-links__download-This">Download (PPT)</a></li></ul></div></figcaption></figure></div></div><div class="section-paragraph">The treatment groups included 1868 patients who were given chloroquine alone, 3016 given hydroxychloroquine alone, 3783 given chloroquine with a macrolide and 6221 given hydroxychloroquine and a macrolide. The median time from hospitalisation to diagnosis of COVID-19 was 2 days (IQR 1–4). The mean daily dose and duration of the various drug regimens were as follows: chloroquine alone, 765 mg (SD 308) and 6·6 days (2·4); hydroxychloroquine alone, 596 mg (126) and 4·2 days (1·9); chloroquine with a macrolide, 790 mg (320) and 6·8 days (2·5); and hydroxychloroquine with a macrolide, 597 mg (128) and 4·3 days (2·0). Additional details of the study cohort are provided in the <a href="#sec1" class="scroll-into-link">appendix (pp 4–5)</a>.</div><div class="section-paragraph">Demographic variables and comorbidities were compared among survivors and non-survivors (<a href="#tbl1" id="back-tbl1" class="scroll-into-link">table 1</a>). Non-survivors were older, more likely to be obese, more likely to be men, more likely to be black or Hispanic, and to have diabetes, hyperlipidaemia, coronary artery disease, congestive heart failure, and a history of arrhythmias. Non-survivors were also more likely to have COPD and to have reported current smoking.<div class="floatDisplay"><div id="tbl1" class="inline-table"><div class="inline-table__head"><span class="inline-table__label">Table 1</span><span class="inline-table__title">Demographics and comorbidities of patients by survival or non-survival during hospitalisation</span></div><table width="100%" cellpadding="0" cellspacing="0" border="0" class="scrollable bordered"><thead><tr><th class="rowsep"></th><th class="rowsep"></th><th class="rowsep"><strong>Survivors (n=85 334)</strong></th><th class="rowsep"><strong>Non-survivors (n=10 698)</strong></th><th class="rowsep"><strong>p value</strong></th></tr></thead><tbody><tr><td colspan="2">Age, years</td><td>53·1 (17·5)</td><td>60·0 (17·6)</td><td>&lt;0·0001</td></tr><tr><td colspan="2">BMI, kg/m<sup>2</sup></td><td>27·0 (5·1)</td><td>31·8 (6·4)</td><td>&lt;0·0001</td></tr><tr><td colspan="2">Obese, BMI &gt;30 kg/m<sup>2</sup></td><td>22 992 (26·9%)</td><td>6518 (60·9%)</td><td>&lt;0·0001</td></tr><tr><td colspan="5">Sex</td></tr><tr><td></td><td>Female</td><td>40 169 (47·1%)</td><td>4257 (39·8%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Male</td><td>45 165 (52·9%)</td><td>6441 (60·2%)</td><td>&lt;0·0001</td></tr><tr><td colspan="5">Race or ethnicity</td></tr><tr><td></td><td>White</td><td>57 503 (67·4%)</td><td>6717 (62·8%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Black</td><td>7219 (8·5%)</td><td>1835 (17·2%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Hispanic</td><td>4948 (5·8%)</td><td>1030 (9·6%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Asian</td><td>12 657 (14·8%)</td><td>862 (8·1%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Native American</td><td>1023 (1·2%)</td><td>56 (0·5%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Other</td><td>1984 (2·3%)</td><td>198 (1·9%)</td><td>0·0019</td></tr><tr><td colspan="5">Comorbidities at baseline</td></tr><tr><td></td><td>Coronary artery disease</td><td>9777 (11·5%)</td><td>2360 (22·1%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Congestive heart failure</td><td>1828 (2·1%)</td><td>540 (5·0%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Arrhythmia</td><td>2700 (3·2%)</td><td>681 (6·4%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Diabetes</td><td>10 963 (12·8%)</td><td>2297 (21·5%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Hypertension</td><td>21 948 (25·7%)</td><td>3862 (36·1%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Hyperlipidaemia</td><td>26 480 (31·0%)</td><td>3718 (34·8%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>COPD</td><td>2603 (3·1%)</td><td>574 (5·4%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Current smoker</td><td>7972 (9·3%)</td><td>1516 (14·2%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Former smoker</td><td>14 681 (17·2%)</td><td>1872 (17·5%)</td><td>0·45</td></tr><tr><td></td><td>Immunocompromised</td><td>2406 (2·8%)</td><td>462 (4·3%)</td><td>&lt;0·0001</td></tr><tr><td colspan="5">Medications</td></tr><tr><td></td><td>ACE inhibitor</td><td>7521 (8·8%)</td><td>428 (4·0%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Statin</td><td>8506 (10·0%)</td><td>739 (6·9%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Angiotensin receptor blocker</td><td>5190 (6·1%)</td><td>659 (6·2%)</td><td>0·75</td></tr><tr><td></td><td>Antiviral</td><td>35 189 (41·2%)</td><td>3738 (34·9%)</td><td>&lt;0·0001</td></tr><tr><td colspan="5">Disease severity</td></tr><tr><td></td><td>qSOFA &lt;1</td><td>71 457 (83·7%)</td><td>7911 (73·9%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>SPO<sub>2</sub> &lt;94%</td><td>7188 (8·4%)</td><td>2129 (19·9%)</td><td>&lt;0·0001</td></tr><tr><td colspan="5">Treatment group</td></tr><tr><td></td><td>Chloroquine alone</td><td>1561 (1·8%)</td><td>307 (2·9%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Chloroquine with macrolide<div class="dropBlock reference-citations"><a href="#" id="back-tbl1fn1" data-db-target-for="tbl1fn1-d12235461e393" class="reference-citations__ctrl scroll-into-link" aria-expanded="false" aria-controls="tbl1fn1">*</a><div data-db-target-of="tbl1fn1-d12235461e393" class="dropBlock__holder"><div class="dropBlock__body"><div class="reference-citations__detials"><span>* </span><span>Macrolides include only azithromycin or clarithromycin.</span></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div></td><td>2944 (3·4%)</td><td>839 (7·8%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Hydroxychloroquine alone</td><td>2473 (2·9%)</td><td>543 (5·1%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Hydroxychloroquine with macrolide<div class="dropBlock reference-citations"><a href="#" id="back-tbl1fn1" data-db-target-for="tbl1fn1-d12235461e415" class="reference-citations__ctrl scroll-into-link" aria-expanded="false" aria-controls="tbl1fn1">*</a><div data-db-target-of="tbl1fn1-d12235461e415" class="dropBlock__holder"><div class="dropBlock__body"><div class="reference-citations__detials"><span>* </span><span>Macrolides include only azithromycin or clarithromycin.</span></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div></td><td>4742 (5·6%)</td><td>1479 (13·8%)</td><td>&lt;0·0001</td></tr><tr><td colspan="5">Outcomes</td></tr><tr><td></td><td>De-novo ventricular arrhythmia</td><td>839 (1·0%)</td><td>400 (3·7%)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Non-ICU length of stay, days</td><td>9·0 (6·2)</td><td>9·8 (7·4)</td><td>&lt;0·0001</td></tr><tr><td></td><td>ICU length of stay, days</td><td>2·1 (3·7)</td><td>9·4 (10·6)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Total length of stay, days</td><td>11·1 (7·3)</td><td>19·2 (14·4)</td><td>&lt;0·0001</td></tr><tr><td></td><td>Mechanical ventilation</td><td>4821 (5·6%)</td><td>4533 (42·4%)</td><td>&lt;0·0001</td></tr></tbody></table><div class="inline-table__tail"><div class="section-paragraph">Data are mean (SD) or n (%). BMI=body-mass index. COPD=chronic obstructive pulmonary disease. ACE=angiotensin-converting enzyme. qSOFA=quick sepsis-related organ failure assessment. SPO<sub>2</sub>=oxygen saturation. ICU=intensive care unit.</div><div class="inline-table__footnote"><span>* </span><span>Macrolides include only azithromycin or clarithromycin.</span></div></div><ul class="rlist--inline separator download-links"><li><a title="Open Full Table" class="table__open__ctrl" target="_blank" href="/action/showFullTableHTML?isHtml=true&amp;tableId=tbl1&amp;pii=S0140-6736%2820%2931180-6">
                            Open table in a new tab
                        </a></li></ul></div></div></div><div class="section-paragraph">The distribution of demographics, comorbidities, and outcomes between the four treatment groups are shown in <a href="#tbl2" id="back-tbl2" class="scroll-into-link">table 2</a>. No significant between-group differences were found among baseline characteristics or comorbidities. Ventricular arrhythmias were more common in the treatment groups compared with the control population. Mortality was higher in the treatment groups compared with the control population (p&lt;0·0001; <a href="#sec1" class="scroll-into-link">appendix pp 15–18</a>).<div class="floatDisplay"><div id="tbl2" class="inline-table"><div class="inline-table__head"><span class="inline-table__label">Table 2</span><span class="inline-table__title">Patient demographics and characteristics by treatment group</span></div><table width="100%" cellpadding="0" cellspacing="0" border="0" class="scrollable bordered"><thead><tr><th class="rowsep"></th><th class="rowsep"></th><th class="rowsep"><strong>Control group (n=81 144)</strong></th><th class="rowsep"><strong>Chloroquine (n=1868)</strong></th><th class="rowsep"><strong>Chloroquine with macrolide</strong><div class="dropBlock reference-citations"><a href="#" id="back-tbl2fn1" data-db-target-for="tbl2fn1-d12235461e514" class="reference-citations__ctrl scroll-into-link" aria-expanded="false" aria-controls="tbl2fn1">*</a><div data-db-target-of="tbl2fn1-d12235461e514" class="dropBlock__holder"><div class="dropBlock__body"><div class="reference-citations__detials"><span>* </span><span>Macrolides include only clarithromycin and azithromycin.</span></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> <strong>(n=3783)</strong></th><th class="rowsep"><strong>Hydroxychloroquine (n=3016)</strong></th><th class="rowsep"><strong>Hydroxychloroquine with macrolide</strong><div class="dropBlock reference-citations"><a href="#" id="back-tbl2fn1" data-db-target-for="tbl2fn1-d12235461e525" class="reference-citations__ctrl scroll-into-link" aria-expanded="false" aria-controls="tbl2fn1">*</a><div data-db-target-of="tbl2fn1-d12235461e525" class="dropBlock__holder"><div class="dropBlock__body"><div class="reference-citations__detials"><span>* </span><span>Macrolides include only clarithromycin and azithromycin.</span></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> <strong>(n=6221)</strong></th></tr></thead><tbody><tr><td colspan="2">Age, years</td><td>53·6 (17·6)</td><td>55·1 (18·0)</td><td>54·9 (17·7)</td><td>55·1 (17·9)</td><td>55·2 (17·7)</td></tr><tr><td colspan="2">BMI, kg/m<sup>2</sup></td><td>27·4 (5·4)</td><td>27·8 (6·1)</td><td>28·2 (5·8)</td><td>28·4 (5.9)</td><td>28·5 (5·9)</td></tr><tr><td colspan="7">Sex</td></tr><tr><td></td><td>Female</td><td>37 716 (46·5%)</td><td>845 (45·2%)</td><td>1718 (45·4%)</td><td>1388 (46·0%)</td><td>2759 (44·3%)</td></tr><tr><td></td><td>Male</td><td>43 428 (53·5%)</td><td>1023 (54·8%)</td><td>2065 (54·6%)</td><td>1628 (54·0%)</td><td>3462 (55·7%)</td></tr><tr><td colspan="7">Race or ethnicity</td></tr><tr><td></td><td>White</td><td>54 403 (67·1%)</td><td>1201 (64·3%)</td><td>2418 (63·9%)</td><td>2074 (68·8%)</td><td>4124 (66·3%)</td></tr><tr><td></td><td>Black</td><td>7519 (9·3%)</td><td>203 (10·9%)</td><td>369 (9·8%)</td><td>287 (9·5%)</td><td>676 (10·9%)</td></tr><tr><td></td><td>Hispanic</td><td>4943 (6·1%)</td><td>108 (5·8%)</td><td>273 (7·2%)</td><td>194 (6·4%)</td><td>460 (7·4%)</td></tr><tr><td></td><td>Asian</td><td>11 504 (14·2%)</td><td>301 (16·1%)</td><td>603 (15·9%)</td><td>366 (12·1%)</td><td>745 (12·0%)</td></tr><tr><td></td><td>Native American</td><td>922 (1·1%)</td><td>19 (1·0%)</td><td>37 (1·0%)</td><td>33 (1·1%)</td><td>68 (1·1%)</td></tr><tr><td></td><td>Other</td><td>1853 (2·3%)</td><td>36 (1·9%)</td><td>83 (2·2%)</td><td>62 (2·1%)</td><td>148 (2·4%)</td></tr><tr><td colspan="7">Comorbidities</td></tr><tr><td></td><td>Coronary artery disease</td><td>10 076 (12·4%)</td><td>284 (15·2%)</td><td>515 (13·6%)</td><td>421 (14·0%)</td><td>841 (13·5%)</td></tr><tr><td></td><td>Congestive heart failure</td><td>1949 (2·4%)</td><td>50 (2·7%)</td><td>103 (2·7%)</td><td>78 (2·6%)</td><td>188 (3·0%)</td></tr><tr><td></td><td>Arrhythmia</td><td>2861 (3·5%)</td><td>63 (3·4%)</td><td>126 (3·3%)</td><td>108 (3·6%)</td><td>223 (3·6%)</td></tr><tr><td></td><td>Diabetes</td><td>11 058 (13·6%)</td><td>258 (13·8%)</td><td>584 (15·4%)</td><td>447 (14·8%)</td><td>913 (14·7%)</td></tr><tr><td></td><td>Hypertension</td><td>21 437 (26·4%)</td><td>560 (30·0%)</td><td>1095 (28·9%)</td><td>891 (29·5%)</td><td>1827 (29·4%)</td></tr><tr><td></td><td>Hyperlipidaemia</td><td>25 538 (31·5%)</td><td>607 (32·5%)</td><td>1164 (30·8%)</td><td>941 (31·2%)</td><td>1948 (31·3%)</td></tr><tr><td></td><td>COPD</td><td>2647 (3·3%)</td><td>55 (2·9%)</td><td>144 (3·8%)</td><td>111 (3·7%)</td><td>220 (3·5%)</td></tr><tr><td></td><td>Current smoker</td><td>7884 (9·7%)</td><td>190 (10·2%)</td><td>428 (11·3%)</td><td>342 (11·3%)</td><td>644 (10·4%)</td></tr><tr><td></td><td>Former smoker</td><td>14 049 (17·3%)</td><td>321 (17·2%)</td><td>648 (17·1%)</td><td>509 (16·9%)</td><td>1026 (16·5%)</td></tr><tr><td></td><td>Immunocompromised</td><td>2416 (3·0%)</td><td>53 (2·8%)</td><td>122 (3·2%)</td><td>90 (3·0%)</td><td>187 (3·0%)</td></tr><tr><td colspan="7">Baseline disease severity</td></tr><tr><td></td><td>qSOFA &lt;1</td><td>67 316 (83·0%)</td><td>1530 (81·9%)</td><td>3051 (80·7%)</td><td>2477 (82·1%)</td><td>4994 (80·3%)</td></tr><tr><td></td><td>SPO<sub>2</sub> &lt;94%</td><td>7721 (9·5%)</td><td>209 (11·2%)</td><td>413 (10·9%)</td><td>323 (10·7%)</td><td>651 (10·5%)</td></tr><tr><td colspan="7">Outcomes</td></tr><tr><td></td><td>De-novo ventricular arrhythmia</td><td>226 (0·3%)</td><td>81 (4·3%)</td><td>246 (6·5%)</td><td>184 (6·1%)</td><td>502 (8·1%)</td></tr><tr><td></td><td>Non-ICU length of stay, days</td><td>9·1 (6·4)</td><td>8·8 (6·2)</td><td>9·0 (6·6)</td><td>8·9 (6·2)</td><td>9·1 (6·7)</td></tr><tr><td></td><td>ICU length of stay, days</td><td>2·6 (5·0)</td><td>4·3 (6·8)</td><td>4·9 (8·1)</td><td>4·3 (6·8)</td><td>4·7 (7·8)</td></tr><tr><td></td><td>Total length of stay, days</td><td>11·7 (8·4)</td><td>13·2 (9·1)</td><td>13·8 (11·0)</td><td>13·2 (9·3)</td><td>13·8 (10·7)</td></tr><tr><td></td><td>Mechanical ventilation</td><td>6278 (7·7%)</td><td>403 (21·6%)</td><td>814 (21·5%)</td><td>616 (20·4%)</td><td>1243 (20·0%)</td></tr><tr><td></td><td>Mortality</td><td>7530 (9·3%)</td><td>307 (16·4%)</td><td>839 (22·2%)</td><td>543 (18·0%)</td><td>1479 (23·8%)</td></tr><tr><td></td><td>Ventilator or mortality</td><td>10 703 (13·2%)</td><td>531 (28·4%)</td><td>1288 (34·0%)</td><td>877 (29·1%)</td><td>2120 (34·1%)</td></tr></tbody></table><div class="inline-table__tail"><div class="section-paragraph">Data are mean (SD) or n (%). BMI=body-mass index. COPD=chronic obstructive pulmonary disease. qSOFA=quick sepsis-related organ failure assessment. SPO<sub>2</sub>=oxygen saturation. ICU=intensive care unit.</div><div class="inline-table__footnote"><span>* </span><span>Macrolides include only clarithromycin and azithromycin.</span></div></div><ul class="rlist--inline separator download-links"><li><a title="Open Full Table" class="table__open__ctrl" target="_blank" href="/action/showFullTableHTML?isHtml=true&amp;tableId=tbl2&amp;pii=S0140-6736%2820%2931180-6">
                            Open table in a new tab
                        </a></li></ul></div></div></div><div class="section-paragraph">Independent predictors of in-hospital mortality are shown in <a data-link="modal" data-target="#image-S0140-6736(20)31180-6gr2" href="#fig2" data-locator="fig2" id="back-gr2" class="figure-link scroll-into-link">figure 2</a>. Age, BMI, black race or Hispanic ethnicity (versus white race), coronary artery disease, congestive heart failure, history of arrhythmia, diabetes, hypertension, hyperlipidaemia, COPD, being a current smoker, and immunosuppressed condition were associated with a higher risk of in-hospital death. Female sex, ethnicity of Asian origin, use of ACE inhibitors (but not angiotensin receptor blockers), and use of statins was associated with reduced in-hospital mortality risk. Compared with the control group (9·3%), hydroxychloroquine alone (18·0%; HR 1·335, 95% CI 1·223–1·457), hydroxychloroquine with a macrolide (23·8%; 1·447, 1·368–1·531), chloroquine alone (16·4%; 1·365, 1·218–1·531), and chloroquine with a macrolide (22·2%; 1·368, 1·273–1·469) were independently associated with an increased risk of in-hospital mortality. The multivariable Cox regression analyses by continent are shown in the <a href="#sec1" class="scroll-into-link">appendix (pp 6–11)</a>, as well as data from the sex-adjusted multivariable logistic regression analyses (pp 12–13) and a separate Cox regression analysis for the combined endpoint of mechanical ventilation or mortality (p 14).<div class="floatDisplay"><figure id="fig2" class=""><img class="b-lazy" data-src="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/011b5689-0d45-48f8-879f-796b46ecabbb/gr2.gif" alt="Figure thumbnail gr2" data-locator="fig2" data-high-res="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a41d9b60-fc5f-4865-857d-730c27e2fed8/gr2_lrg.gif" data-large-image="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/011b5689-0d45-48f8-879f-796b46ecabbb/gr2.gif"></img><figcaption><div class="figure__caption__body"><div class="figure__title"><span data-fv-label="Fig. 2" class="label figure__label">Figure 2</span><span class="figure__title__text">Independent predictors of in-hospital mortality</span></div><div class="accordion"><a href="#" class="accordion__control" aria-expanded="false"><i class="icon-section_arrow_d"></i><span>Show full caption</span></a><div class="accordion__content"><div class="figure__caption__text"><div class="section-paragraph">Age and BMI are continuous variables. The 95% CIs have not been adjusted for multiple testing and should not be used to infer definitive effects. ACE=angiotensin-converting enzyme. BMI=body mass index. COPD=chronic obstructive pulmonary disease. HR=hazard ratio. qSOFA=quick sepsis-related organ failure assessment. SPO<sub>2</sub>=oxygen saturation.</div></div></div></div><ul class="rlist--inline separator download-links"><li><a target="_blank" href="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/011b5689-0d45-48f8-879f-796b46ecabbb/gr2.gif" title="View Large Image in a new tab">View Large
                                            Image
                                        </a></li><li class="download-links__figureViewer"><a href="#" class="figure__open__ctrl">Figure Viewer</a></li><li><a href="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a41d9b60-fc5f-4865-857d-730c27e2fed8/gr2_lrg.gif" class="download-links__download-Hi-res" target="_blank" download="">Download Hi-res
                                            image
                                        </a></li><li class="hidden-xs"><a href="/action/downloadFigures?pii=S0140-6736(20)31180-6&amp;id=gr2.gif" class="download-links__download-This">Download (PPT)</a></li></ul></div></figcaption></figure></div></div><div class="section-paragraph">Independent predictors of ventricular arrythmia are shown in <a data-link="modal" data-target="#image-S0140-6736(20)31180-6gr3" href="#fig3" data-locator="fig3" id="back-gr3" class="figure-link scroll-into-link">figure 3</a>. Coronary artery disease, congestive heart failure, history of cardiac arrhythmia, and COPD were independently associated with an increased risk of de-novo ventricular arrhythmias during hospitalisation. Compared with the control group (0·3%), hydroxychloroquine alone (6·1%; HR 2·369, 95% CI 1·935–2·900), hydroxychloroquine with a macrolide (8·1%; 5·106, 4·106–5·983), chloroquine alone (4·3%; 3·561, 2·760–4·596), and chloroquine with a macrolide (6·5%; 4·011, 3·344–4·812) were independently associated with an increased risk of de-novo ventricular arrhythmia during hospitalisation.<div class="floatDisplay"><figure id="fig3" class=""><img class="b-lazy" data-src="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9bcc79c5-75cd-4301-bde8-8c64cb075c0a/gr3.gif" alt="Figure thumbnail gr3" data-locator="fig3" data-high-res="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d80c0b45-7944-4627-b202-22b4e1cdde9b/gr3_lrg.gif" data-large-image="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9bcc79c5-75cd-4301-bde8-8c64cb075c0a/gr3.gif"></img><figcaption><div class="figure__caption__body"><div class="figure__title"><span data-fv-label="Fig. 3" class="label figure__label">Figure 3</span><span class="figure__title__text">Independent predictors of ventricular arrhythmias during hospitalisation</span></div><div class="accordion"><a href="#" class="accordion__control" aria-expanded="false"><i class="icon-section_arrow_d"></i><span>Show full caption</span></a><div class="accordion__content"><div class="figure__caption__text"><div class="section-paragraph">Age and BMI are continuous variables. The 95% CIs have not been adjusted for multiple testing and should not be used to infer definitive effects. ACE=angiotensin-converting enzyme. BMI=body mass index. COPD=chronic obstructive pulmonary disease. HR=hazard ratio. qSOFA=quick sepsis-related organ failure assessment. SPO<sub>2</sub>=oxygen saturation.</div></div></div></div><ul class="rlist--inline separator download-links"><li><a target="_blank" href="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9bcc79c5-75cd-4301-bde8-8c64cb075c0a/gr3.gif" title="View Large Image in a new tab">View Large
                                            Image
                                        </a></li><li class="download-links__figureViewer"><a href="#" class="figure__open__ctrl">Figure Viewer</a></li><li><a href="//els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d80c0b45-7944-4627-b202-22b4e1cdde9b/gr3_lrg.gif" class="download-links__download-Hi-res" target="_blank" download="">Download Hi-res
                                            image
                                        </a></li><li class="hidden-xs"><a href="/action/downloadFigures?pii=S0140-6736(20)31180-6&amp;id=gr3.gif" class="download-links__download-This">Download (PPT)</a></li></ul></div></figcaption></figure></div></div><div class="section-paragraph">Analyses using propensity score matching by treatment group are shown in the <a href="#sec1" class="scroll-into-link">appendix (pp 15–18)</a>. The results indicated that the associations between the drug regimens and mortality, need for mechanical ventilation, length of stay, and the occurrence of de-novo ventricular arrhythmias were consistent with the primary analysis.</div><div class="section-paragraph">A tipping point analysis was done to assess the effects of an unmeasured confounder on the findings of significance with hydroxychloroquine or chloroquine (<a href="#sec1" class="scroll-into-link">appendix pp 19–20</a>). For chloroquine, hydroxychloroquine, and chloroquine with a macrolide, a hypothetical unobserved binary confounder with a prevalence of 50% in the exposed population would need to have an HR of 1·5 to tip this analysis to non-significance at the 5% level. For a comparison with the observed confounders in this study, if congestive heart failure (which has an HR of 1·756) were left out of the model, it would need to have a prevalence of approximately 30% in the population to lead to confounding in the analysis. Similarly, for hydroxychloroquine with a macrolide, a hypothetical unobserved binary confounder with a prevalence of 37% in the exposed population would need to have an HR of 2·0 to tip this analysis to non-significance at the 5% level. Again, congestive heart failure (which has an HR of 1·756) would need to have a prevalence of approximately 50% in the population to lead to confounding in the analysis, had it not been adjusted for in the Cox proportional hazards model.</div></section><section id="cesec100" data-locator="cesec100"><h2 class="top" id="seccestitle160" data-left-hand-nav="Discussion"><span class="top__sub"></span><span class="top__text">Discussion</span></h2><div class="section-paragraph">In this large multinational real-world analysis, we did not observe any benefit of hydroxychloroquine or chloroquine (when used alone or in combination with a macrolide) on in-hospital outcomes, when initiated early after diagnosis of COVID-19. Each of the drug regimens of chloroquine or hydroxychloroquine alone or in combination with a macrolide was associated with an increased hazard for clinically significant occurrence of ventricular arrhythmias and increased risk of in-hospital death with COVID-19.</div><div class="section-paragraph">The use of hydroxychloroquine or chloroquine in COVID-19 is based on widespread publicity of small, uncontrolled studies, which suggested that the combination of hydroxychloroquine with the macrolide azithromycin was successful in clearing viral replication.<div class="dropBlock reference-citations"><sup><a href="#bib7" id="back-bib7" data-db-target-for="bib7-d12235461e1341" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib7">7</a></sup><div data-db-target-of="bib7-d12235461e1341" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Gautret P </li><li class="loa__item">Lagier JC </li><li class="loa__item">Parola P </li><li>et al.</li></ul><div class="reference-citations__detials">Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.<div class="popup-ref"><span class="ref__series"><i>Int J Antimicrob Agents.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 20.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.ijantimicag.2020.105949" target="_blank">DOI:10.1016/j.ijantimicag.2020.105949</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Int+J+Antimicrob+Agents&author=Gautret+P&author=Lagier+JC&author=Parola+P&title=Hydroxychloroquine+and+azithromycin+as+a+treatment+of+COVID-19%3A+results+of+an+open-label+non-randomized+clinical+trial">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> On March 28, 2020, the FDA issued an emergency use authorisation for these drugs in patients if clinical trial access was unavailable.<div class="dropBlock reference-citations"><sup><a href="#bib12" id="back-bib12" data-db-target-for="bib12-d12235461e1345" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib12">12</a></sup><div data-db-target-of="bib12-d12235461e1345" class="dropBlock__holder"><div class="dropBlock__body"><div class="reference-citations__detials"><span>US Food and Drug Administration</span><br />Emergency use authorization: coronavirus disease 2019 (COVID-19) EUA information.<div class="popup-ref"><div class="citation-host"><a href="https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidtherapeutics" target="_blank">https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidtherapeutics</a><div><span>Date accessed: </span>May 15, 2020</div></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=US+Food+and+Drug+AdministrationEmergency+use+authorization%3A+coronavirus+disease+2019+%28COVID-19%29+EUA+information.https%3A%2F%2Fwww.fda.gov%2Femergency-preparedness-and-response%2Fmcm-legal-regulatory-and-policy-framework%2Femergency-use-authorization%23covidtherapeuticsDate+accessed%3A+May+15%2C+2020">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Other countries, such as China, have issued guidelines allowing for the use of chloroquine in COVID-19.<div class="dropBlock reference-citations"><sup><a href="#bib13" id="back-bib13" data-db-target-for="bib13-d12235461e1349" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib13">13</a></sup><div data-db-target-of="bib13-d12235461e1349" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Gao J </li><li class="loa__item">Tian Z </li><li class="loa__item">Yang X </li></ul><div class="reference-citations__detials">Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.<div class="popup-ref"><span class="ref__series"><i>Biosci Trends.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">14</span></span>: <span class="ref__seriesPages">72-73</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2020&pages=72-73&journal=Biosci+Trends&author=Gao+J&author=Tian+Z&author=Yang+X&title=Breakthrough%3A+chloroquine+phosphate+has+shown+apparent+efficacy+in+treatment+of+COVID-19+associated+pneumonia+in+clinical+studies">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Several countries have been stockpiling the drugs, and shortages of them for approved indications, such as for autoimmune disease and rheumatoid arthritis, have been encountered.<div class="dropBlock reference-citations"><sup><a href="#bib10" id="back-bib10" data-db-target-for="bib10-d12235461e1353" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib10">10</a></sup><div data-db-target-of="bib10-d12235461e1353" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Peschken CA </li></ul><div class="reference-citations__detials">Possible consequences of a shortage of hydroxychloroquine for patients with systemic lupus erythematosus amid the COVID-19 pandemic.<div class="popup-ref"><span class="ref__series"><i>J Rheumatol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 8.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.3899/jrheum.200395" target="_blank">DOI:10.3899/jrheum.200395</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=J+Rheumatol&author=Peschken+CA&title=Possible+consequences+of+a+shortage+of+hydroxychloroquine+for+patients+with+systemic+lupus+erythematosus+amid+the+COVID-19+pandemic">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> A retrospective observational review of 368 men with COVID-19 treated at the US Veterans Affairs hospitals raised concerns that the use of hydroxychloroquine was associated with a greater hazard of death; however, the baseline characteristics among the groups analysed were dissimilar and the possibility of bias cannot be ruled out.<div class="dropBlock reference-citations"><sup><a href="#bib14" id="back-bib14" data-db-target-for="bib14-d12235461e1357" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib14">14</a></sup><div data-db-target-of="bib14-d12235461e1357" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Magagnoli J </li><li class="loa__item">Narendran S </li><li class="loa__item">Pereira F </li><li>et al.</li></ul><div class="reference-citations__detials">Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19.<div class="popup-ref"><span class="ref__series"><i>medRxiv.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 23.</span>) <span class="refComment">(preprint).</span></span><div class="citation-host"><a href="http://dx.doi.org/10.1101/2020.04.16.20065920" target="_blank">DOI: 10.1101/2020.04.16.20065920</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=medRxiv&author=Magagnoli+J&author=Narendran+S&author=Pereira+F&title=Outcomes+of+hydroxychloroquine+usage+in+United+States+veterans+hospitalized+with+COVID-19">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Another observational study in 181 patients from France reported that the use of hydroxychloroquine at a dose of 600 mg per day was not associated with a measurable clinical benefit in patients with COVID-19 pneumonia.<div class="dropBlock reference-citations"><sup><a href="#bib15" id="back-bib15" data-db-target-for="bib15-d12235461e1362" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib15">15</a></sup><div data-db-target-of="bib15-d12235461e1362" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Mahevas M </li><li class="loa__item">Tran V-T </li><li class="loa__item">Roumier M </li><li>et al.</li></ul><div class="reference-citations__detials">No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection with oxygen requiremenr: results of a study using routinely collected data to emulate a target trial.<div class="popup-ref"><span class="ref__series"><i>medRxiv.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 14.</span>) <span class="refComment">(preprint).</span></span><div class="citation-host"><a href="http://dx.doi.org/10.1101/2020.04.10.20060699" target="_blank">DOI: 10.1101/2020.04.10.20060699</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=medRxiv&author=Mahevas+M&author=Tran+V-T&author=Roumier+M&title=No+evidence+of+clinical+efficacy+of+hydroxychloroquine+in+patients+hospitalised+for+COVID-19+infection+with+oxygen+requiremenr%3A+results+of+a+study+using+routinely+collected+data+to+emulate+a+target+trial">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Our large-scale, international, real-world analysis supports the absence of a clinical benefit of chloroquine and hydroxychloroquine and points to potential harm in hospitalised patients with COVID-19.</div><div class="section-paragraph">Chloroquine and hydroxychloroquine are associated with concerns of cardiovascular toxicity, particularly because of their known relationship with electrical instability, characterised by QT interval prolongation (the time taken for ventricular depolarisation and repolarisation). This mechanism relates to blockade of the hERG potassium channel,<div class="dropBlock reference-citations"><sup><a href="#bib16" id="back-bib16" data-db-target-for="bib16-d12235461e1368" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib16">16</a></sup><div data-db-target-of="bib16-d12235461e1368" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Traebert M </li><li class="loa__item">Dumotier B </li><li class="loa__item">Meister L </li><li class="loa__item">Hoffmann P </li><li class="loa__item">Dominguez-Estevez M </li><li class="loa__item">Suter W </li></ul><div class="reference-citations__detials">Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells.<div class="popup-ref"><span class="ref__series"><i>Eur J Pharmacol.</i> <span class="ref__seriesDate">2004; </span><span class="ref__seriesVolume">484</span></span>: <span class="ref__seriesPages">41-48</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=484&publication_year=2004&pages=41-48&journal=Eur+J+Pharmacol&author=Traebert+M&author=Dumotier+B&author=Meister+L&author=Hoffmann+P&author=Dominguez-Estevez+M&author=Suter+W&title=Inhibition+of+hERG+K%2B+currents+by+antimalarial+drugs+in+stably+transfected+HEK293+cells">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> which lengthens ventricular repolarisation and the duration of ventricular action potentials. Under specific conditions, early after-depolarisations can trigger ventricular arrhythmias.<div class="dropBlock reference-citations"><sup><a href="#bib9" id="back-bib9" data-db-target-for="bib9-d12235461e1372" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib9">9</a></sup><div data-db-target-of="bib9-d12235461e1372" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Giudicessi JR </li><li class="loa__item">Noseworthy PA </li><li class="loa__item">Friedman PA </li><li class="loa__item">Ackerman MJ </li></ul><div class="reference-citations__detials">Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19).<div class="popup-ref"><span class="ref__series"><i>Mayo Clin Proc.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 7.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.mayocp.2020.03.024" target="_blank">DOI:10.1016/j.mayocp.2020.03.024</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Mayo+Clin+Proc&author=Giudicessi+JR&author=Noseworthy+PA&author=Friedman+PA&author=Ackerman+MJ&title=Urgent+guidance+for+navigating+and+circumventing+the+QTc-prolonging+and+torsadogenic+potential+of+possible+pharmacotherapies+for+coronavirus+disease+19+%28COVID-19%29">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Such propensity for arrhythmia provocation is more often seen in individuals with structural cardiovascular disease, and cardiac injury has been reported to occur with high frequency during COVID-19 illness.<div class="dropBlock reference-citations"><sup><a href="#" id="back-bib17" data-db-target-for="bib17-d12235461e1376" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib17">17</a></sup><div data-db-target-of="bib17-d12235461e1376" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Shi S </li><li class="loa__item">Qin M </li><li class="loa__item">Shen B </li><li>et al.</li></ul><div class="reference-citations__detials">Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.<div class="popup-ref"><span class="ref__series"><i>JAMA Cardiol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 25.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1001/jamacardio.2020.0950" target="_blank">DOI:10.1001/jamacardio.2020.0950</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=JAMA+Cardiol&author=Shi+S&author=Qin+M&author=Shen+B&title=Association+of+cardiac+injury+with+mortality+in+hospitalized+patients+with+COVID-19+in+Wuhan%2C+China">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><sup>, </sup> <div class="dropBlock reference-citations"><sup><a href="#" id="back-bib18" data-db-target-for="bib18-d12235461e1376" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib18">18</a></sup><div data-db-target-of="bib18-d12235461e1376" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Guo T </li><li class="loa__item">Fan Y </li><li class="loa__item">Chen M </li><li>et al.</li></ul><div class="reference-citations__detials">Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).<div class="popup-ref"><span class="ref__series"><i>JAMA Cardiol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 27.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1001/jamacardio.2020.1017" target="_blank">DOI:10.1001/jamacardio.2020.1017</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=JAMA+Cardiol&author=Guo+T&author=Fan+Y&author=Chen+M&title=Cardiovascular+implications+of+fatal+outcomes+of+patients+with+coronavirus+disease+2019+%28COVID-19%29">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Furthermore, individuals with cardiovascular disease represent a vulnerable population that experience worse outcomes with COVID-19.<div class="dropBlock reference-citations"><sup><a href="#" id="back-bib19" data-db-target-for="bib19-d12235461e1380" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib19">19</a></sup><div data-db-target-of="bib19-d12235461e1380" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Bonow RO </li><li class="loa__item">Fonarow GC </li><li class="loa__item">O'Gara PT </li><li class="loa__item">Yancy CW </li></ul><div class="reference-citations__detials">Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality.<div class="popup-ref"><span class="ref__series"><i>JAMA Cardiol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 27.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1001/jamacardio.2020.1105" target="_blank">DOI:10.1001/jamacardio.2020.1105</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=JAMA+Cardiol&author=Bonow+RO&author=Fonarow+GC&author=O%27Gara+PT&author=Yancy+CW&title=Association+of+coronavirus+disease+2019+%28COVID-19%29+with+myocardial+injury+and+mortality">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><sup>, </sup> <div class="dropBlock reference-citations"><sup><a href="#" id="back-bib20" data-db-target-for="bib20-d12235461e1380" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib20">20</a></sup><div data-db-target-of="bib20-d12235461e1380" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Mehra MR </li><li class="loa__item">Desai SS </li><li class="loa__item">Kuy S </li><li class="loa__item">Henry TD </li><li class="loa__item">Patel AN </li></ul><div class="reference-citations__detials">Cardiovascular disease, drug therapy, and mortality in COVID-19.<div class="popup-ref"><span class="ref__series"><i>N Engl J Med.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 1.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1056/NEJMoa2007621" target="_blank">DOI:10.1056/NEJMoa2007621</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=N+Engl+J+Med&author=Mehra+MR&author=Desai+SS&author=Kuy+S&author=Henry+TD&author=Patel+AN&title=Cardiovascular+disease%2C+drug+therapy%2C+and+mortality+in+COVID-19">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Pathological studies have pointed to derangements in the vascular endothelium and a diffuse endotheliitis noted across multiple organs in COVID-19.<div class="dropBlock reference-citations"><sup><a href="#bib21" id="back-bib21" data-db-target-for="bib21-d12235461e1384" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib21">21</a></sup><div data-db-target-of="bib21-d12235461e1384" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Varga Z </li><li class="loa__item">Flammer AJ </li><li class="loa__item">Steiger P </li><li>et al.</li></ul><div class="reference-citations__detials">Endothelial cell infection and endotheliitis in COVID-19.<div class="popup-ref"><span class="ref__series"><i>Lancet.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">395</span></span>: <span class="ref__seriesPages">1417-1418</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=1417-1418&journal=Lancet&author=Varga+Z&author=Flammer+AJ&author=Steiger+P&title=Endothelial+cell+infection+and+endotheliitis+in+COVID-19">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Whether patients with underlying cardiovascular disease and those that experience de-novo cardiovascular injury have a greater predilection to ventricular arrhythmias with chloroquine or its analogues remains uncertain but plausible. COVID-19 is exemplified by initial viral replication followed by enhanced systemic inflammation.<div class="dropBlock reference-citations"><sup><a href="#bib22" id="back-bib22" data-db-target-for="bib22-d12235461e1389" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib22">22</a></sup><div data-db-target-of="bib22-d12235461e1389" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Siddiqi HK </li><li class="loa__item">Mehra MR </li></ul><div class="reference-citations__detials">COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal.<div class="popup-ref"><span class="ref__series"><i>J Heart Lung Transplant.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">39</span></span>: <span class="ref__seriesPages">405-407</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2020&pages=405-407&journal=J+Heart+Lung+Transplant&author=Siddiqi+HK&author=Mehra+MR&title=COVID-19+illness+in+native+and+immunosuppressed+states%3A+a+clinical-therapeutic+staging+proposal">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> The use of chloroquine or hydroxychloroquine in combination with a macrolide is designed to use their antimicrobial properties in a synergistic manner.<div class="dropBlock reference-citations"><sup><a href="#bib23" id="back-bib23" data-db-target-for="bib23-d12235461e1393" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib23">23</a></sup><div data-db-target-of="bib23-d12235461e1393" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Nakornchai S </li><li class="loa__item">Konthiang P </li></ul><div class="reference-citations__detials">Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant <em>Plasmodium falciparum</em> in vitro.<div class="popup-ref"><span class="ref__series"><i>Acta Trop.</i> <span class="ref__seriesDate">2006; </span><span class="ref__seriesVolume">100</span></span>: <span class="ref__seriesPages">185-191</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2006&pages=185-191&journal=Acta+Trop&author=Nakornchai+S&author=Konthiang+P&title=Activity+of+azithromycin+or+erythromycin+in+combination+with+antimalarial+drugs+against+multidrug-resistant+Plasmodium+falciparum+in+vitro">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> Macrolides, such as azithromycin and clarithromycin, are antibiotics with immunomodulatory and anti-inflammatory effects.<div class="dropBlock reference-citations"><sup><a href="#bib24" id="back-bib24" data-db-target-for="bib24-d12235461e1397" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib24">24</a></sup><div data-db-target-of="bib24-d12235461e1397" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Lee N </li><li class="loa__item">Wong CK </li><li class="loa__item">Chan MCW </li><li>et al.</li></ul><div class="reference-citations__detials">Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: a randomized controlled trial.<div class="popup-ref"><span class="ref__series"><i>Antiviral Res.</i> <span class="ref__seriesDate">2017; </span><span class="ref__seriesVolume">144</span></span>: <span class="ref__seriesPages">48-56</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2017&pages=48-56&journal=Antiviral+Res&author=Lee+N&author=Wong+CK&author=Chan+MCW&title=Anti-inflammatory+effects+of+adjunctive+macrolide+treatment+in+adults+hospitalized+with+influenza%3A+a+randomized+controlled+trial">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> However, these drugs prolong the QT interval and increase the risk of sudden cardiac death.<div class="dropBlock reference-citations"><sup><a href="#" id="back-bib8" data-db-target-for="bib8-d12235461e1401" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib8">8</a></sup><div data-db-target-of="bib8-d12235461e1401" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Ray WA </li><li class="loa__item">Murray KT </li><li class="loa__item">Hall K </li><li class="loa__item">Arbogast PG </li><li class="loa__item">Stein CM </li></ul><div class="reference-citations__detials">Azithromycin and the risk of cardiovascular death.<div class="popup-ref"><span class="ref__series"><i>N Engl J Med.</i> <span class="ref__seriesDate">2012; </span><span class="ref__seriesVolume">366</span></span>: <span class="ref__seriesPages">1881-1890</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=1881-1890&journal=N+Engl+J+Med&author=Ray+WA&author=Murray+KT&author=Hall+K&author=Arbogast+PG&author=Stein+CM&title=Azithromycin+and+the+risk+of+cardiovascular+death">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><sup>, </sup> <div class="dropBlock reference-citations"><sup><a href="#" id="back-bib9" data-db-target-for="bib9-d12235461e1401" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib9">9</a></sup><div data-db-target-of="bib9-d12235461e1401" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Giudicessi JR </li><li class="loa__item">Noseworthy PA </li><li class="loa__item">Friedman PA </li><li class="loa__item">Ackerman MJ </li></ul><div class="reference-citations__detials">Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19).<div class="popup-ref"><span class="ref__series"><i>Mayo Clin Proc.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 7.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.mayocp.2020.03.024" target="_blank">DOI:10.1016/j.mayocp.2020.03.024</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Mayo+Clin+Proc&author=Giudicessi+JR&author=Noseworthy+PA&author=Friedman+PA&author=Ackerman+MJ&title=Urgent+guidance+for+navigating+and+circumventing+the+QTc-prolonging+and+torsadogenic+potential+of+possible+pharmacotherapies+for+coronavirus+disease+19+%28COVID-19%29">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> In a preliminary analysis, Borba and colleagues<div class="dropBlock reference-citations"><sup><a href="#bib25" id="back-bib25" data-db-target-for="bib25-d12235461e1405" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib25">25</a></sup><div data-db-target-of="bib25-d12235461e1405" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Borba MGS </li><li class="loa__item">Val FFA </li><li class="loa__item">Sampaio VS </li><li>et al.</li></ul><div class="reference-citations__detials">Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial.<div class="popup-ref"><span class="ref__series"><i>JAMA Netw Open.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">3</span></span>e208857</div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&journal=JAMA+Netw+Open&author=Borba+MGS&author=Val+FFA&author=Sampaio+VS&title=Effect+of+high+vs+low+doses+of+chloroquine+diphosphate+as+adjunctive+therapy+for+patients+hospitalized+with+severe+acute+respiratory+syndrome+coronavirus+2+%28SARS-CoV-2%29+infection%3A+a+randomized+clinical+trial">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> reported a double-blind, randomised trial with 81 adult patients who were hospitalised with severe COVID-19 at a tertiary care facility in Brazil. This study suggested that a higher dose of chloroquine represented a safety hazard, especially when taken concurrently with azithromycin and oseltamivir. In another cohort study of 90 patients with COVID-19 pneumonia, Mercuro and colleagues<div class="dropBlock reference-citations"><sup><a href="#bib26" id="back-bib26" data-db-target-for="bib26-d12235461e1409" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib26">26</a></sup><div data-db-target-of="bib26-d12235461e1409" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Mercuro NJ </li><li class="loa__item">Yen CF </li><li class="loa__item">Shim DJ </li><li>et al.</li></ul><div class="reference-citations__detials">Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19).<div class="popup-ref"><span class="ref__series"><i>JAMA Cardiol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 1.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1001/jamacardio.2020.1834" target="_blank">DOI:10.1001/jamacardio.2020.1834</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=JAMA+Cardiol&author=Mercuro+NJ&author=Yen+CF&author=Shim+DJ&title=Risk+of+QT+interval+prolongation+associated+with+use+of+hydroxychloroquine+with+or+without+concomitant+azithromycin+among+hospitalized+patients+testing+positive+for+coronavirus+disease+2019+%28COVID-19%29">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> found that the concomitant use of a macrolide was associated with a greater change in the corrected QT interval. Our study did not examine the QT interval but instead directly analysed the risk of clinically significant ventricular arrythmias. We showed an independent association of the use of either hydroxychloroquine or chloroquine with the occurrence of de-novo ventricular arrhythmias. We also note that the hazard of de-novo ventricular arrhythmias increased when the drugs were used in combination with a macrolide.</div><div class="section-paragraph">In our analysis, which was dominated by patients from North America, we noted that higher BMI emerged as a risk marker for worse in-hospital survival. Obesity is a known risk factor for cardiac arrhythmias and sudden cardiac death.<div class="dropBlock reference-citations"><sup><a href="#" id="back-bib27" data-db-target-for="bib27-d12235461e1415" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib27">27</a></sup><div data-db-target-of="bib27-d12235461e1415" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Lavie CJ </li><li class="loa__item">Arena R </li><li class="loa__item">Alpert MA </li><li class="loa__item">Milani RV </li><li class="loa__item">Ventura HO </li></ul><div class="reference-citations__detials">Management of cardiovascular diseases in patients with obesity.<div class="popup-ref"><span class="ref__series"><i>Nat Rev Cardiol.</i> <span class="ref__seriesDate">2018; </span><span class="ref__seriesVolume">15</span></span>: <span class="ref__seriesPages">45-56</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=45-56&journal=Nat+Rev+Cardiol&author=Lavie+CJ&author=Arena+R&author=Alpert+MA&author=Milani+RV&author=Ventura+HO&title=Management+of+cardiovascular+diseases+in+patients+with+obesity">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div><sup>, </sup> <div class="dropBlock reference-citations"><sup><a href="#" id="back-bib28" data-db-target-for="bib28-d12235461e1415" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib28">28</a></sup><div data-db-target-of="bib28-d12235461e1415" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Sanchis-Gomar F </li><li class="loa__item">Lavie CJ </li><li class="loa__item">Mehra MR </li><li class="loa__item">Henry BM </li><li class="loa__item">Lippi G </li></ul><div class="reference-citations__detials">Obesity and outcomes in COVID-19: when an epidemic and pandemic collide.<div class="popup-ref"><span class="ref__series"><i>Mayo Clin Proc.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 19.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.mayocp.2020.05.006" target="_blank">DOI:10.1016/j.mayocp.2020.05.006</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Mayo+Clin+Proc&author=Sanchis-Gomar+F&author=Lavie+CJ&author=Mehra+MR&author=Henry+BM&author=Lippi+G&title=Obesity+and+outcomes+in+COVID-19%3A+when+an+epidemic+and+pandemic+collide">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> The most commonly reported arrhythmias are atrial fibrillation and ventricular tachycardia. Although age, race, and BMI were predictive of an increased risk for death with COVID-19 in our analysis, they were not found to be associated with an increased risk of ventricular arrhythmias on our multivariable regression analysis. The only variables found to be independently predictive of ventricular arrhythmias were the four treatment regimens, along with underlying cardiovascular disease and COPD. Thus, the presence of cardiovascular comorbidity in the study population could partially explain the observed risk of increased cardiovascular toxicity with the use of chloroquine or hydroxychloroquine, especially when used in combination with macrolides. In this investigation, consistent with our previous findings in a smaller cohort of 8910 patients,<div class="dropBlock reference-citations"><sup><a href="#bib20" id="back-bib20" data-db-target-for="bib20-d12235461e1419" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib20">20</a></sup><div data-db-target-of="bib20-d12235461e1419" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Mehra MR </li><li class="loa__item">Desai SS </li><li class="loa__item">Kuy S </li><li class="loa__item">Henry TD </li><li class="loa__item">Patel AN </li></ul><div class="reference-citations__detials">Cardiovascular disease, drug therapy, and mortality in COVID-19.<div class="popup-ref"><span class="ref__series"><i>N Engl J Med.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 1.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1056/NEJMoa2007621" target="_blank">DOI:10.1056/NEJMoa2007621</a></div></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=N+Engl+J+Med&author=Mehra+MR&author=Desai+SS&author=Kuy+S&author=Henry+TD&author=Patel+AN&title=Cardiovascular+disease%2C+drug+therapy%2C+and+mortality+in+COVID-19">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div> we found that women and patients being treated with ACE inhibitors (but not angiotensin receptor blockers) or statins had lower mortality with COVID-19. These findings imply that drugs that stabilise cardiovascular function and improve endothelial cell dysfunction might improve prognosis, independent of the use of cardiotoxic drug combinations.<div class="dropBlock reference-citations"><sup><a href="#bib21" id="back-bib21" data-db-target-for="bib21-d12235461e1423" class="reference-citations__ctrl" aria-expanded="false" aria-controls="bib21">21</a></sup><div data-db-target-of="bib21-d12235461e1423" class="dropBlock__holder"><div class="dropBlock__body"><ul title="list of authors" class="rlist reference-citations__loa inline-bullet-list"><li class="loa__item">Varga Z </li><li class="loa__item">Flammer AJ </li><li class="loa__item">Steiger P </li><li>et al.</li></ul><div class="reference-citations__detials">Endothelial cell infection and endotheliitis in COVID-19.<div class="popup-ref"><span class="ref__series"><i>Lancet.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">395</span></span>: <span class="ref__seriesPages">1417-1418</span></div></div><div class="reference-citations__links"><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=1417-1418&journal=Lancet&author=Varga+Z&author=Flammer+AJ&author=Steiger+P&title=Endothelial+cell+infection+and+endotheliitis+in+COVID-19">Google Scholar</a></li></ul></div></div><a href="#" class="dropBlock__ctrl--close" title="Close info"><i aria-hidden="true" class="icon-close_thin"></i></a></div></div></div><div class="section-paragraph">Our study has several limitations. The association of decreased survival with hydroxychloroquine or chloroquine treatment regimens should be interpreted cautiously. Due to the observational study design, we cannot exclude the possibility of unmeasured confounding factors, although we have reassuringly noted consistency between the primary analysis and the propensity score matched analyses. Nevertheless, a cause-and-effect relationship between drug therapy and survival should not be inferred. These data do not apply to the use of any treatment regimen used in the ambulatory, out-of-hospital setting. Randomised clinical trials will be required before any conclusion can be reached regarding benefit or harm of these agents in COVID-19 patients. We also note that although we evaluated the relationship of the drug treatment regimens with the occurrence of ventricular arrhythmias, we did not measure QT intervals, nor did we stratify the arrhythmia pattern (such as torsade de pointes). We also did not establish if the association of increased risk of in-hospital death with use of the drug regimens is linked directly to their cardiovascular risk, nor did we conduct a drug dose-response analysis of the observed risks. Even if these limitations suggest a conservative interpretation of the findings, we believe that the absence of any observed benefit could still represent a reasonable explanation.</div><div class="section-paragraph">In summary, this multinational, observational, real-world study of patients with COVID-19 requiring hospitalisation found that the use of a regimen containing hydroxychloroquine or chloroquine (with or without a macrolide) was associated with no evidence of benefit, but instead was associated with an increase in the risk of ventricular arrhythmias and a greater hazard for in-hospital death with COVID-19. These findings suggest that these drug regimens should not be used outside of clinical trials and urgent confirmation from randomised clinical trials is needed.</div></section><div class="section-paragraph"><strong>Contributors</strong></div><div class="section-paragraph">The study was conceived and designed by MRM and ANP. Acquisition of data and statistical analysis of the data were supervised and performed by SSD. MRM drafted the manuscript and all authors participated in critical revision of the manuscript for important intellectual content. MRM and ANP supervised the study. All authors approved the final manuscript and were responsible for the decision to submit for publication.</div><div class="section-paragraph"><strong>Declaration of interests</strong></div><div class="section-paragraph">MRM reports personal fees from Abbott, Medtronic, Janssen, Mesoblast, Portola, Bayer, Baim Institute for Clinical Research, NupulseCV, FineHeart, Leviticus, Roivant, and Triple Gene. SSD is the founder of Surgisphere Corporation. FR has been paid for time spent as a committee member for clinical trials, advisory boards, other forms of consulting, and lectures or presentations; these payments were made directly to the University of Zurich and no personal payments were received in relation to these trials or other activities. ANP declares no competing interests.</div><section><div class="section-paragraph"><strong>Acknowledgments</strong></div><div class="section-paragraph">The development and maintenance of the Surgical Outcomes Collaborative database was funded by Surgisphere Corporation (Chicago, IL, USA). This study was supported by the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women's Hospital (Boston, MA, USA). We acknowledge Jide Olayinka (Surgisphere) for their helpful statistical review of the manuscript.</div></section><section id="sec1" data-locator="sec1"><h2 class="top" id="seccestitle170" data-left-hand-nav="Supplementary Material"><span class="top__sub"></span><span class="top__text">Supplementary Material</span></h2><div class="section-paragraph supplemental-information"><ul class="rlist"><li class="supplemental-information__item" id="ecomp10"><div class="supplemental-information__icon icon-gizmo-pdf-file2"></div><div class="supplemental-information__links clearfix"><div class="col-sm-6 gutterless"><a href="/cms/10.1016/S0140-6736(20)31180-6/attachment/84423d57-4cf8-41d0-99ca-0e921f2c80ce/mmc1.pdf" class="supplemental-information__download " target="_blank">
                                            Download .pdf (.6
                                            MB)
                                        </a></div><div class="col-sm-6 gutterless"><a href="https://service.elsevier.com/app/answers/detail/a_id/19286/supporthub/sciencedirect/" class="supplemental-information__help " target="_blank">
                                    Help with
                                    pdf files
                                </a></div></div><div class="supplemental-information__title">Supplementary appendix</div></li></ul></div></section><div data-pb-dropzone="extra-dropzone" class="extra-dropzone pb-dropzone"><!-- Empty dropzone --></div><section class="refs"><h2 class="top" id="seccestitle180" data-left-hand-nav="References"><span class="top__sub"></span><span class="top__text">References</span></h2><ol class="ref__wrapper"><li class="ref"><span class="refLabel">1.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Principi N </li><li class="ref__authors__name">Esposito S </li></ul><div class="ref__title">Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.</div><span class="ref__series"><i>Lancet Infect Dis.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 17.</span>)</span><div class="citation-host"><a href="https://doi.org/10.1016/S1473-3099(20)30296-6" target="_blank">https://doi.org/10.1016/S1473-3099(20)30296-6</a></div><div class="ref__controls"><a href="#back-bib1" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Lancet+Infect+Dis&author=Principi+N&author=Esposito+S&title=Chloroquine+or+hydroxychloroquine+for+prophylaxis+of+COVID-19">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">2.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Perricone C </li><li class="ref__authors__name">Triggianese P </li><li class="ref__authors__name">Bartoloni E </li><li>et al.</li></ul><div class="ref__title">The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19.</div><span class="ref__series"><i>J Autoimmun.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 17.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.jaut.2020.102468" target="_blank">DOI:10.1016/j.jaut.2020.102468</a></div><div class="ref__controls"><a href="#back-bib2" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=J+Autoimmun&author=Perricone+C&author=Triggianese+P&author=Bartoloni+E&title=The+anti-viral+facet+of+anti-rheumatic+drugs%3A+lessons+from+COVID-19">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">3.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Liu J </li><li class="ref__authors__name">Cao R </li><li class="ref__authors__name">Xu M </li><li>et al.</li></ul><div class="ref__title">Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.</div><span class="ref__series"><i>Cell Discov.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">6</span></span>: <span class="ref__seriesPages">16</span><div class="ref__controls"><a href="#back-bib3" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=16&journal=Cell+Discov&author=Liu+J&author=Cao+R&author=Xu+M&title=Hydroxychloroquine%2C+a+less+toxic+derivative+of+chloroquine%2C+is+effective+in+inhibiting+SARS-CoV-2+infection+in+vitro">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">4.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Devaux CA </li><li class="ref__authors__name">Rolain JM </li><li class="ref__authors__name">Colson P </li><li class="ref__authors__name">Raoult D </li></ul><div class="ref__title">New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?.</div><span class="ref__series"><i>Int J Antimicrob Agents.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 12.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.ijantimicag.2020.105938" target="_blank">DOI:10.1016/j.ijantimicag.2020.105938</a></div><div class="ref__controls"><a href="#back-bib4" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Int+J+Antimicrob+Agents&author=Devaux+CA&author=Rolain+JM&author=Colson+P&author=Raoult+D&title=New+insights+on+the+antiviral+effects+of+chloroquine+against+coronavirus%3A+what+to+expect+for+COVID-19%3F">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">5.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Tang W </li><li class="ref__authors__name">Cao Z </li><li class="ref__authors__name">Han M </li><li>et al.</li></ul><div class="ref__title">Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial.</div><span class="ref__series"><i>medRxiv.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 7.</span>) <span class="refComment">(preprint).</span></span><div class="citation-host"><a href="http://dx.doi.org/10.1101/2020.04.10.20060558" target="_blank">DOI: 10.1101/2020.04.10.20060558</a></div><div class="ref__controls"><a href="#back-bib5" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=medRxiv&author=Tang+W&author=Cao+Z&author=Han+M&title=Hydroxychloroquine+in+patients+mainly+with+mild+to+moderate+COVID-19%3A+an+open-label%2C+randomized%2C+controlled+trial">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">6.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Chen J </li><li class="ref__authors__name">Liu D </li><li class="ref__authors__name">Liu L </li><li>et al.</li></ul><div class="ref__title">A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19.</div><span class="ref__series"><i>J Zhejiang Univ (Med Sci).</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">49</span></span>: <span class="ref__seriesPages">215-219</span><div class="ref__controls"><a href="#back-bib6" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2020&pages=215-219&journal=J+Zhejiang+Univ+%28Med+Sci%29&author=Chen+J&author=Liu+D&author=Liu+L&title=A+pilot+study+of+hydroxychloroquine+in+treatment+of+patients+with+moderate+COVID-19">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">7.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Gautret P </li><li class="ref__authors__name">Lagier JC </li><li class="ref__authors__name">Parola P </li><li>et al.</li></ul><div class="ref__title">Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.</div><span class="ref__series"><i>Int J Antimicrob Agents.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 20.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.ijantimicag.2020.105949" target="_blank">DOI:10.1016/j.ijantimicag.2020.105949</a></div><div class="ref__controls"><a href="#back-bib7" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Int+J+Antimicrob+Agents&author=Gautret+P&author=Lagier+JC&author=Parola+P&title=Hydroxychloroquine+and+azithromycin+as+a+treatment+of+COVID-19%3A+results+of+an+open-label+non-randomized+clinical+trial">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">8.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Ray WA </li><li class="ref__authors__name">Murray KT </li><li class="ref__authors__name">Hall K </li><li class="ref__authors__name">Arbogast PG </li><li class="ref__authors__name">Stein CM </li></ul><div class="ref__title">Azithromycin and the risk of cardiovascular death.</div><span class="ref__series"><i>N Engl J Med.</i> <span class="ref__seriesDate">2012; </span><span class="ref__seriesVolume">366</span></span>: <span class="ref__seriesPages">1881-1890</span><div class="ref__controls"><a href="#back-bib8" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=1881-1890&journal=N+Engl+J+Med&author=Ray+WA&author=Murray+KT&author=Hall+K&author=Arbogast+PG&author=Stein+CM&title=Azithromycin+and+the+risk+of+cardiovascular+death">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">9.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Giudicessi JR </li><li class="ref__authors__name">Noseworthy PA </li><li class="ref__authors__name">Friedman PA </li><li class="ref__authors__name">Ackerman MJ </li></ul><div class="ref__title">Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19).</div><span class="ref__series"><i>Mayo Clin Proc.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 7.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.mayocp.2020.03.024" target="_blank">DOI:10.1016/j.mayocp.2020.03.024</a></div><div class="ref__controls"><a href="#back-bib9" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Mayo+Clin+Proc&author=Giudicessi+JR&author=Noseworthy+PA&author=Friedman+PA&author=Ackerman+MJ&title=Urgent+guidance+for+navigating+and+circumventing+the+QTc-prolonging+and+torsadogenic+potential+of+possible+pharmacotherapies+for+coronavirus+disease+19+%28COVID-19%29">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">10.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Peschken CA </li></ul><div class="ref__title">Possible consequences of a shortage of hydroxychloroquine for patients with systemic lupus erythematosus amid the COVID-19 pandemic.</div><span class="ref__series"><i>J Rheumatol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 8.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.3899/jrheum.200395" target="_blank">DOI:10.3899/jrheum.200395</a></div><div class="ref__controls"><a href="#back-bib10" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=J+Rheumatol&author=Peschken+CA&title=Possible+consequences+of+a+shortage+of+hydroxychloroquine+for+patients+with+systemic+lupus+erythematosus+amid+the+COVID-19+pandemic">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">11.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li>WHO</li></ul><div class="ref__title">Clinical management of severe acute respiratory infection (SARI) when novel COVID-19 disease is suspected: interim guidance.</div><div class="citation-host"><a href="https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf" target="_blank">https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf</a><div><span>Date: </span>March 13, 2020</div><div><span>Date accessed: </span>April 24, 2020</div></div><div class="ref__controls"><a href="#back-bib11" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=March+13%2C+2020&author=WHO&title=Clinical+management+of+severe+acute+respiratory+infection+%28SARI%29+when+novel+COVID-19+disease+is+suspected%3A+interim+guidance">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">12.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li>US Food and Drug Administration</li></ul><div class="ref__title">Emergency use authorization: coronavirus disease 2019 (COVID-19) EUA information.</div><div class="citation-host"><a href="https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidtherapeutics" target="_blank">https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidtherapeutics</a><div><span>Date accessed: </span>May 15, 2020</div></div><div class="ref__controls"><a href="#back-bib12" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=US+Food+and+Drug+AdministrationEmergency+use+authorization%3A+coronavirus+disease+2019+%28COVID-19%29+EUA+information.https%3A%2F%2Fwww.fda.gov%2Femergency-preparedness-and-response%2Fmcm-legal-regulatory-and-policy-framework%2Femergency-use-authorization%23covidtherapeuticsDate+accessed%3A+May+15%2C+2020">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">13.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Gao J </li><li class="ref__authors__name">Tian Z </li><li class="ref__authors__name">Yang X </li></ul><div class="ref__title">Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.</div><span class="ref__series"><i>Biosci Trends.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">14</span></span>: <span class="ref__seriesPages">72-73</span><div class="ref__controls"><a href="#back-bib13" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2020&pages=72-73&journal=Biosci+Trends&author=Gao+J&author=Tian+Z&author=Yang+X&title=Breakthrough%3A+chloroquine+phosphate+has+shown+apparent+efficacy+in+treatment+of+COVID-19+associated+pneumonia+in+clinical+studies">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">14.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Magagnoli J </li><li class="ref__authors__name">Narendran S </li><li class="ref__authors__name">Pereira F </li><li>et al.</li></ul><div class="ref__title">Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19.</div><span class="ref__series"><i>medRxiv.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 23.</span>) <span class="refComment">(preprint).</span></span><div class="citation-host"><a href="http://dx.doi.org/10.1101/2020.04.16.20065920" target="_blank">DOI: 10.1101/2020.04.16.20065920</a></div><div class="ref__controls"><a href="#back-bib14" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=medRxiv&author=Magagnoli+J&author=Narendran+S&author=Pereira+F&title=Outcomes+of+hydroxychloroquine+usage+in+United+States+veterans+hospitalized+with+COVID-19">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">15.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Mahevas M </li><li class="ref__authors__name">Tran V-T </li><li class="ref__authors__name">Roumier M </li><li>et al.</li></ul><div class="ref__title">No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection with oxygen requiremenr: results of a study using routinely collected data to emulate a target trial.</div><span class="ref__series"><i>medRxiv.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online April 14.</span>) <span class="refComment">(preprint).</span></span><div class="citation-host"><a href="http://dx.doi.org/10.1101/2020.04.10.20060699" target="_blank">DOI: 10.1101/2020.04.10.20060699</a></div><div class="ref__controls"><a href="#back-bib15" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=medRxiv&author=Mahevas+M&author=Tran+V-T&author=Roumier+M&title=No+evidence+of+clinical+efficacy+of+hydroxychloroquine+in+patients+hospitalised+for+COVID-19+infection+with+oxygen+requiremenr%3A+results+of+a+study+using+routinely+collected+data+to+emulate+a+target+trial">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">16.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Traebert M </li><li class="ref__authors__name">Dumotier B </li><li class="ref__authors__name">Meister L </li><li class="ref__authors__name">Hoffmann P </li><li class="ref__authors__name">Dominguez-Estevez M </li><li class="ref__authors__name">Suter W </li></ul><div class="ref__title">Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells.</div><span class="ref__series"><i>Eur J Pharmacol.</i> <span class="ref__seriesDate">2004; </span><span class="ref__seriesVolume">484</span></span>: <span class="ref__seriesPages">41-48</span><div class="ref__controls"><a href="#back-bib16" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=484&publication_year=2004&pages=41-48&journal=Eur+J+Pharmacol&author=Traebert+M&author=Dumotier+B&author=Meister+L&author=Hoffmann+P&author=Dominguez-Estevez+M&author=Suter+W&title=Inhibition+of+hERG+K%2B+currents+by+antimalarial+drugs+in+stably+transfected+HEK293+cells">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">17.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Shi S </li><li class="ref__authors__name">Qin M </li><li class="ref__authors__name">Shen B </li><li>et al.</li></ul><div class="ref__title">Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.</div><span class="ref__series"><i>JAMA Cardiol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 25.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1001/jamacardio.2020.0950" target="_blank">DOI:10.1001/jamacardio.2020.0950</a></div><div class="ref__controls"><a href="#back-bib17" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=JAMA+Cardiol&author=Shi+S&author=Qin+M&author=Shen+B&title=Association+of+cardiac+injury+with+mortality+in+hospitalized+patients+with+COVID-19+in+Wuhan%2C+China">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">18.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Guo T </li><li class="ref__authors__name">Fan Y </li><li class="ref__authors__name">Chen M </li><li>et al.</li></ul><div class="ref__title">Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).</div><span class="ref__series"><i>JAMA Cardiol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 27.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1001/jamacardio.2020.1017" target="_blank">DOI:10.1001/jamacardio.2020.1017</a></div><div class="ref__controls"><a href="#back-bib18" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=JAMA+Cardiol&author=Guo+T&author=Fan+Y&author=Chen+M&title=Cardiovascular+implications+of+fatal+outcomes+of+patients+with+coronavirus+disease+2019+%28COVID-19%29">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">19.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Bonow RO </li><li class="ref__authors__name">Fonarow GC </li><li class="ref__authors__name">O'Gara PT </li><li class="ref__authors__name">Yancy CW </li></ul><div class="ref__title">Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality.</div><span class="ref__series"><i>JAMA Cardiol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online March 27.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1001/jamacardio.2020.1105" target="_blank">DOI:10.1001/jamacardio.2020.1105</a></div><div class="ref__controls"><a href="#back-bib19" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=JAMA+Cardiol&author=Bonow+RO&author=Fonarow+GC&author=O%27Gara+PT&author=Yancy+CW&title=Association+of+coronavirus+disease+2019+%28COVID-19%29+with+myocardial+injury+and+mortality">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">20.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Mehra MR </li><li class="ref__authors__name">Desai SS </li><li class="ref__authors__name">Kuy S </li><li class="ref__authors__name">Henry TD </li><li class="ref__authors__name">Patel AN </li></ul><div class="ref__title">Cardiovascular disease, drug therapy, and mortality in COVID-19.</div><span class="ref__series"><i>N Engl J Med.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 1.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1056/NEJMoa2007621" target="_blank">DOI:10.1056/NEJMoa2007621</a></div><div class="ref__controls"><a href="#back-bib20" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=N+Engl+J+Med&author=Mehra+MR&author=Desai+SS&author=Kuy+S&author=Henry+TD&author=Patel+AN&title=Cardiovascular+disease%2C+drug+therapy%2C+and+mortality+in+COVID-19">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">21.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Varga Z </li><li class="ref__authors__name">Flammer AJ </li><li class="ref__authors__name">Steiger P </li><li>et al.</li></ul><div class="ref__title">Endothelial cell infection and endotheliitis in COVID-19.</div><span class="ref__series"><i>Lancet.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">395</span></span>: <span class="ref__seriesPages">1417-1418</span><div class="ref__controls"><a href="#back-bib21" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=1417-1418&journal=Lancet&author=Varga+Z&author=Flammer+AJ&author=Steiger+P&title=Endothelial+cell+infection+and+endotheliitis+in+COVID-19">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">22.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Siddiqi HK </li><li class="ref__authors__name">Mehra MR </li></ul><div class="ref__title">COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal.</div><span class="ref__series"><i>J Heart Lung Transplant.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">39</span></span>: <span class="ref__seriesPages">405-407</span><div class="ref__controls"><a href="#back-bib22" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2020&pages=405-407&journal=J+Heart+Lung+Transplant&author=Siddiqi+HK&author=Mehra+MR&title=COVID-19+illness+in+native+and+immunosuppressed+states%3A+a+clinical-therapeutic+staging+proposal">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">23.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Nakornchai S </li><li class="ref__authors__name">Konthiang P </li></ul><div class="ref__title">Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant <em>Plasmodium falciparum</em> in vitro.</div><span class="ref__series"><i>Acta Trop.</i> <span class="ref__seriesDate">2006; </span><span class="ref__seriesVolume">100</span></span>: <span class="ref__seriesPages">185-191</span><div class="ref__controls"><a href="#back-bib23" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2006&pages=185-191&journal=Acta+Trop&author=Nakornchai+S&author=Konthiang+P&title=Activity+of+azithromycin+or+erythromycin+in+combination+with+antimalarial+drugs+against+multidrug-resistant+Plasmodium+falciparum+in+vitro">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">24.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Lee N </li><li class="ref__authors__name">Wong CK </li><li class="ref__authors__name">Chan MCW </li><li>et al.</li></ul><div class="ref__title">Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: a randomized controlled trial.</div><span class="ref__series"><i>Antiviral Res.</i> <span class="ref__seriesDate">2017; </span><span class="ref__seriesVolume">144</span></span>: <span class="ref__seriesPages">48-56</span><div class="ref__controls"><a href="#back-bib24" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2017&pages=48-56&journal=Antiviral+Res&author=Lee+N&author=Wong+CK&author=Chan+MCW&title=Anti-inflammatory+effects+of+adjunctive+macrolide+treatment+in+adults+hospitalized+with+influenza%3A+a+randomized+controlled+trial">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">25.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Borba MGS </li><li class="ref__authors__name">Val FFA </li><li class="ref__authors__name">Sampaio VS </li><li>et al.</li></ul><div class="ref__title">Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial.</div><span class="ref__series"><i>JAMA Netw Open.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume">3</span></span>e208857<div class="ref__controls"><a href="#back-bib25" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&journal=JAMA+Netw+Open&author=Borba+MGS&author=Val+FFA&author=Sampaio+VS&title=Effect+of+high+vs+low+doses+of+chloroquine+diphosphate+as+adjunctive+therapy+for+patients+hospitalized+with+severe+acute+respiratory+syndrome+coronavirus+2+%28SARS-CoV-2%29+infection%3A+a+randomized+clinical+trial">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">26.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Mercuro NJ </li><li class="ref__authors__name">Yen CF </li><li class="ref__authors__name">Shim DJ </li><li>et al.</li></ul><div class="ref__title">Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19).</div><span class="ref__series"><i>JAMA Cardiol.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 1.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1001/jamacardio.2020.1834" target="_blank">DOI:10.1001/jamacardio.2020.1834</a></div><div class="ref__controls"><a href="#back-bib26" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=JAMA+Cardiol&author=Mercuro+NJ&author=Yen+CF&author=Shim+DJ&title=Risk+of+QT+interval+prolongation+associated+with+use+of+hydroxychloroquine+with+or+without+concomitant+azithromycin+among+hospitalized+patients+testing+positive+for+coronavirus+disease+2019+%28COVID-19%29">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">27.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Lavie CJ </li><li class="ref__authors__name">Arena R </li><li class="ref__authors__name">Alpert MA </li><li class="ref__authors__name">Milani RV </li><li class="ref__authors__name">Ventura HO </li></ul><div class="ref__title">Management of cardiovascular diseases in patients with obesity.</div><span class="ref__series"><i>Nat Rev Cardiol.</i> <span class="ref__seriesDate">2018; </span><span class="ref__seriesVolume">15</span></span>: <span class="ref__seriesPages">45-56</span><div class="ref__controls"><a href="#back-bib27" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=45-56&journal=Nat+Rev+Cardiol&author=Lavie+CJ&author=Arena+R&author=Alpert+MA&author=Milani+RV&author=Ventura+HO&title=Management+of+cardiovascular+diseases+in+patients+with+obesity">Google Scholar</a></li></ul></div></li><li class="ref"><span class="refLabel">28.</span><ul title="list of authors" class="rlist inline-bullet-list ref__authors ref__inline-block"><li class="ref__authors__name">Sanchis-Gomar F </li><li class="ref__authors__name">Lavie CJ </li><li class="ref__authors__name">Mehra MR </li><li class="ref__authors__name">Henry BM </li><li class="ref__authors__name">Lippi G </li></ul><div class="ref__title">Obesity and outcomes in COVID-19: when an epidemic and pandemic collide.</div><span class="ref__series"><i>Mayo Clin Proc.</i> <span class="ref__seriesDate">2020; </span><span class="ref__seriesVolume"></span> (<span class="refComment">published online May 19.</span>)</span><div class="citation-host"><a href="http://dx.doi.org/10.1016/j.mayocp.2020.05.006" target="_blank">DOI:10.1016/j.mayocp.2020.05.006</a></div><div class="ref__controls"><a href="#back-bib28" title="View in Article" class="ref__controls__viewInArticle scroll-into-link">View
                        in Article
                        <i class="icon-section_arrow_u"></i></a><ul class="rlist inline-bullet-list"><li><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&journal=Mayo+Clin+Proc&author=Sanchis-Gomar+F&author=Lavie+CJ&author=Mehra+MR&author=Henry+BM&author=Lippi+G&title=Obesity+and+outcomes+in+COVID-19%3A+when+an+epidemic+and+pandemic+collide">Google Scholar</a></li></ul></div></li></ol></section><section class="article-info"><h2 class="top" id="articleInformation">Article Info</h2><section><h3 class="publicationHistory__label">Publication History</h3><div class="article-info__dates"><div class="article-info__date">Published: May 22, 2020</div></div></section><section><h3>Identification</h3><p>DOI: <a href="https://doi.org/10.1016/S0140-6736(20)31180-6">https://doi.org/10.1016/S0140-6736(20)31180-6</a></p></section><section><h3>Copyright</h3><div class="copyright">© 2020 Elsevier Ltd. All rights reserved.</div></section><section><h3>ScienceDirect</h3><a href="https://www.sciencedirect.com/science/article/pii/S0140673620311806">Access this article on ScienceDirect</a></section></section><div id="figure-viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title"></div></nav><div class="frames"><ul class="frames__list"></ul><a href="#" title="Previous figure" class="frameButton previousFrameButton frames__prev"><i class="icon-arrow_l"></i></a><a href="#" title="Next figure" class="frameButton nextFrameButton frames__next"><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in article</span></a></div><div class="thumbstrip"><a class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li><a target="_blank" href="#" title="View Large Image in a new tab" class="viewLargeImage"><i class="icon icon-gizmo-image_figure figure-viewer__download__viewer-size-icon"></i><span class="figure-viewer__download__text">View Large Image</span></a></li><li><a target="_blank" href="#" title="View high resolution image in a new tab" class="downloadThisButton" download=""><i class="icon icon-gizmo-image_figure figure-viewer__download__viewer-size-icon"></i><span class="figure-viewer__download__text">Download Hi-res image </span></a></li><li class="hidden-xs hidden-sm"><a href="#" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><div class="figures-placeholder"></div><div class="tables-placeholder"></div>
    

        


    

            

            

            <section data-widget-id="7c530872-6235-4433-899c-b3f276970189" data-widget-name="UX3linkedContentList"><h2 id="section-7c530872-6235-4433-899c-b3f276970189" class="top">Linked Articles</h2><div class="section-paragraph linked-article"><ul class="rlist"><li class="linked-article__item"><a href="/journals/lancet/article/PIIS0140-6736(20)31174-0/fulltext" title="Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?" class="linked-article__title">Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?</a><div class="linked-article__labels"></div><div class="linked-article__details"></div><ul class="rlist rlist--inline linked-article__links clearfix"><li class="bulleted"><a href="/journals/lancet/article/PIIS0140-6736(20)31174-0/fulltext" title="Full-Text" class="faded">Full-Text</a></li><li><a href="/pdfs/journals/lancet/PIIS0140-6736(20)31174-0.pdf" title="PDF" target="_blank">PDF</a></li></ul></li></ul></div></section>

            

        

    

        


    

            

            

            <div data-pb-widget-type="ux3-storyCard" data-widget-id="47be90a1-303e-4ae1-883d-0bcc5c82d5de" data-widget-name="UX3StoryCardStack" class="ux3DeferredWidget" data-journal-code="lancet" data-pii="S0140-6736(20)31180-6"></div>

            

        

    

        


    

            

            

            <div data-pb-widget-type="ux3-lancetCollection" data-widget-id="3d6acba1-acea-4be2-8dc9-b7e14e5b6583" data-widget-name="UX3ArticleLancetCollections" data-article-pii="S0140673620311806" class="ux3DeferredWidget"></div>

            

        

    

        


    

            

            

            <div data-pb-widget-type="ux3-storyCard" data-widget-id="8fcef2ae-bfef-496b-b1cc-8d9a0ea1a989" data-widget-name="UX3StoryCardStack" class="ux3DeferredWidget" data-journal-code="lancet" data-pii="S0140-6736(20)31180-6"></div>

            

        

    

        


    

            

            

            <div data-pb-widget-type="ux3-storyCard" data-widget-id="909e3ba9-52f8-40e5-8e72-6e74dcb4e86b" data-widget-name="UX3StoryCardStack" class="ux3DeferredWidget" data-journal-code="lancet" data-pii="S0140-6736(20)31180-6"></div>

            

        

    

        


    

            

            

            <div data-pb-widget-type="ux3-storyTeaser" data-widget-id="e1237f8f-fba8-421f-b6e0-cb008ca30e95" data-widget-name="UX3storyTeaserView" class="ux3DeferredWidget" data-journal-code="lancet" data-pii="S0140-6736(20)31180-6"></div>

            

        

    

        


    

            

            

            <div data-pb-widget-type="ux3-storyTeaser" data-widget-id="6579bef7-5b75-4233-bc6b-5a5dda60726a" data-widget-name="UX3storyTeaserView" class="ux3DeferredWidget" data-journal-code="lancet" data-pii="S0140-6736(20)31180-6"></div>

            

        

    

        


    

            

            

            <div data-pb-widget-type="ux3-storyTeaser" data-widget-id="693a86d5-def0-4c8a-be40-235cf5297fbb" data-widget-name="UX3storyTeaserView" class="ux3DeferredWidget" data-journal-code="lancet" data-pii="S0140-6736(20)31180-6"></div>

            

        

    

        


    

        


    

        


    

        


    

        


    

        


    

        


    

        


    

        


    

        

<div id="figure-viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title"></div></nav><div class="frames"><ul class="frames__list"></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li><a target="_blank" href="/specs/products/marlin/components/figure-viewer/images/facets-2015-0010-f10-standard.jpg" title="View high resolution image in a new tab" class="downloadThisButton"><i class="icon icon-gizmo-image_figure figure-viewer__download__viewer-size-icon"></i><span class="figure-viewer__download__text">Download Hi-res image</span></a></li><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?articleNumber=e00489" target="_blank" title="Doanload .PPT" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT </span></a></li></ul></div></div><div data-toggle="transplant" data-direction="from" data-transplant="self" data-target=".adplaceholder--slot2, .adplaceholder--slot3 " data-remove="false" class="adplaceholder__transplant hidden-md hidden-lg"></div></div><div class="col-md-3 col-lg-2"></div></div></div></div></article>

            

        

        </main>
    
</div></div>

            
                </div>
            

        

        </div>
    










        <div data-widget-def="ux3-layout-widget" data-widget-id="1f4bb806-6f34-4378-a41c-8b5060df84ee" class="ux3">
        
    

        


    

            

            

            <div data-widget-id="1f4bb806-6f34-4378-a41c-8b5060df84ee" data-widget-name="ux3-layout-widget"><footer class="footer clearfix">
    

        


    

            

            

            <div data-widget-id="6c6b6950-d88f-47eb-a4a3-88a4d54a3efe" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="The Lancet logo"><img alt="logo" src="/pb-assets/ux3/logos/lancet/LANCET-1532516601370.svg"></a></div>
        <div class="footer__social-links">
                                                <ul class="rlist rlist--inline centered">
                <li><a href="https://twitter.com/TheLancet" title="Twitter"><i aria-hidden="true" class="icon-Icon_Twitter"></i></a></li>
                <li><a href="https://www.facebook.com/TheLancetMedicalJournal/" title="Facebook"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>
                <li><a href="https://www.linkedin.com/company/the-lancet/" title="LinkedIn"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
                                                                
                                                                <li><a href="https://www.youtube.com/user/TheLancetTV" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
                                                                
                                                                <li><a href="http://weibo.com/TheLancetChina" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
                                                                
                                                                <li><a href="//els-jbs-prod-cdn.jbs.elsevierhealth.com/pb-assets/Lancet/marketing/wechat/WeChat_website-1559811717053.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
															<li><a href="/podcasts" title="Podcasts" target="_blank"><svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 29 29" enable-background="new 0 0 29 29" xml:space="preserve">
<g>
                <path fill="#969696" d="M19.8,17.5L19.8,17.5c-0.3,0.7-0.7,1.3-1.3,1.9c-1,1-2.5,1.6-4,1.6s-3-0.6-4.1-1.7c-0.5-0.5-1-1.2-1.3-1.9
                                L9,17l-1.7,0.7l0.2,0.4c0.4,0.9,0.9,1.8,1.7,2.5c1.2,1.2,2.8,2,4.5,2.2v2.4h-1.9v1.9h5.7v-1.9h-1.9v-2.4c1.7-0.2,3.3-1,4.5-2.2
                                c0.7-0.7,1.3-1.6,1.7-2.5l0.2-0.4L20,17L19.8,17.5z"></path>
                <path fill="#969696" d="M14.5,19.1c2.4,0,4.4-2,4.4-4.4V8.4c0-2.4-2-4.4-4.4-4.4s-4.4,2-4.4,4.4v6.3C10.1,17.1,12.1,19.1,14.5,19.1
                                z"></path>
                <path fill="#969696" d="M25.5,2.6l-0.3-0.3l-1.3,1.3l0.3,0.3c1.3,1.3,2,3.1,2,4.9c0,1.9-0.7,3.6-2,4.9L23.9,14l1.3,1.3l0.3-0.3
                                c1.7-1.7,2.6-3.9,2.6-6.3S27.2,4.3,25.5,2.6z"></path>
                <path fill="#969696" d="M22,5.5l-1.3,1.3L21,7.1c0.5,0.5,0.7,1.1,0.7,1.7c0,0.7-0.3,1.3-0.7,1.7l-0.3,0.3l1.3,1.3l0.3-0.3
                                c0.8-0.8,1.3-1.9,1.3-3.1s-0.5-2.2-1.3-3.1L22,5.5z"></path>
                <path fill="#969696" d="M5.2,3.6L3.8,2.3L3.5,2.6C1.8,4.3,0.9,6.5,0.9,8.8s0.9,4.6,2.6,6.3l0.3,0.3l1.3-1.3l-0.3-0.3
                                c-1.3-1.3-2-3.1-2-4.9c0-1.9,0.7-3.6,2-4.9L5.2,3.6z"></path>
                <path fill="#969696" d="M8,10.6c-0.5-0.5-0.7-1.1-0.7-1.7c0-0.7,0.3-1.3,0.7-1.7l0.3-0.3L7,5.5L6.7,5.8c-0.8,0.8-1.2,1.9-1.2,3
                                C5.5,10,6,11,6.8,11.9L7,12.2l1.3-1.3L8,10.6z"></path>
</g>
</svg></a></li>

            </ul>
        </div>
</div>

<style>

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="990712f4-2a7a-4439-a11d-411ecf08e5c8" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="21f1d838-df27-4e30-80c7-1b97df750391" data-widget-name="UX3HTMLWidget"><div class="groups bordered">
                    <div class="group">
                      <div class="group__title">The Lancet Journals</div>
                      <ul class="rlist clearfix sided">
                        <li><a href="/journals/lancet/home">The Lancet</a></li>
                        <li><a href="/journals/lanchi/home">The Lancet Child &amp; Adolescent Health</a></li>
                        <li><a href="/journals/landia/home">The Lancet Diabetes &amp; Endocrinology</a></li>
                        <li><a href="/journals/landig/home">The Lancet Digital Health</a></li>
                        <li><a href="/journals/langas/home">The Lancet Gastroenterology &amp; Hepatology</a></li>
                        <li><a href="/journals/langlo/home">The Lancet Global Health</a></li>
                        <li><a href="/journals/lanhae/home">The Lancet Haematology</a></li>
                        <li><a href="/journals/lanhiv/home">The Lancet HIV</a></li>
                        <li><a href="/journals/laninf/home">The Lancet Infectious Diseases</a></li>
                        <li><a href="/journals/lanmic/home">The Lancet Microbe</a></li>
                        <li><a href="/journals/laneur/home">The Lancet Neurology</a></li>
                        <li><a href="/journals/lanonc/home">The Lancet Oncology</a></li>
                        <li><a href="/journals/lanplh/home">The Lancet Planetary Health</a></li>
                        <li><a href="/journals/lanpsy/home">The Lancet Psychiatry</a></li>
                        <li><a href="/journals/lanpub/home">The Lancet Public Health</a></li>
                        <li><a href="/regional-health">The Lancet Regional Health</a></li>                        
                        <li><a href="/journals/lanres/home">The Lancet Respiratory Medicine</a></li>
                        <li><a href="/journals/lanrhe/home">The Lancet Rheumatology</a></li>
                        <li><a href="/journals/ebiom/home">EBioMedicine</a></li>
                        <li><a href="/journals/eclinm/home">EClinicalMedicine</a></li>
                      </ul>
                    </div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-3 col-lg-2 clearfix">
    

        


    

            

            

            <div data-widget-id="6a7e5150-5321-421f-8ce9-0223e8bdc674" data-widget-name="UX3HTMLWidget"><div class="groups bordered">
                    <div class="group">
                      <div class="group__title">CLINICAL</div>
                      <ul class="rlist clearfix">
                        <li><a href="/clinical/diseases">The Lancet Clinic</a></li>
                        <li><a href="/clinical/commissions">Commissions</a></li>
                        <li><a href="/clinical/series">Series</a></li>
                        <li><a href="/picture-quiz">Picture Quiz</a></li>
                      </ul>
                    </div>
                    <div class="group">
                      <div class="group__title">GLOBAL HEALTH</div>
                      <ul class="rlist clearfix">
                        <li><a href="/global-health">Hub</a></li>
                        <li><a href="/global-health/commissions">Commissions</a></li>
                        <li><a href="/global-health/series">Series</a></li>
                        <li><a href="/gbd">Global Burden of Disease</a></li>
                      </ul>
                    </div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-4 col-lg-5 clearfix">
    

        


    

            

            

            <div data-widget-id="7e537560-25b2-4b1b-8d93-8fe6767a5b3a" data-widget-name="UX3HTMLWidget"><div class="groups ">
                    <div class="group">
                      <div class="group__title">Connect</div>
                      <ul class="rlist clearfix sided">
                        <li><a href="/about-us">About</a></li>
                        <li><a href="/contact-us">Contact Us</a></li>
                        <li><a href="https://service.elsevier.com/app/overview/lancet/" target="_blank">Customer Service</a></li>
                      </ul>
                    </div>
                    <div class="group">
                      <div class="group__title">Access</div>
                      <ul class="rlist clearfix sided">
                        <li><a href="/access-to-content">Information for Readers</a></li>
                        <li><a href="/action/registration?journal=&amp;redirectUri=https%3A%2F%2Fwww.thelancet.com%2F">Register</a></li>
                        <li><a href="/journals/lancet/subscribe">Subscription Options</a></li>
                        <li><a href="/action/showPreferences?menuTab=AccountInfo">My Account</a></li>
                        <li><a href="/action/activateClaim?journalCode=&amp;class=claimSubscribtion">Existing Print Subscribers</a></li>
                        <li><a href="http://info.thelancet.com/update-alerts?utm_campaign=tlupdates-signup&amp;utm_source=footer&amp;utm_medium=tlwebsite&amp;utm_content=updates " target="_blank">The Lancet <i>Updates</i></a></li>
                        <li><a href="http://info.thelancet.com/request-access?utm_campaign=jls-rtl&amp;utm_source=site-footer&amp;utm_medium=website " target="_blank">Recommend Lancet journals to your librarian</a></li>
                        <li><a href="/app">The Lancet App</a></li>
                        <li><a href="/choice">The Lancet Choice</a></li>
                      </ul>
                    </div>
                    <div class="group">
                      <div class="group__title">Information</div>
                      <ul class="rlist clearfix sided">
                        <li><a href="/for-authors">Authors</a></li>
                        <li><a href="/press-room">Press</a></li>
                        <li><a href="/for-advertisers">Advertisers</a></li>
                        <li><a href="http://careers.thelancet.com/home" target="_blank">Careers</a></li>
                        <li><a href="https://www.elsevier.com/legal/privacy-policy" target="_blank">Privacy Policy</a></li>
                        <li><a href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions" target="_blank">Terms and Conditions</a></li>
                        <li><a href="/cookies">Cookies</a></li>
                      </ul>
                    </div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="d3dbd9c8-ebaf-468d-bc43-063d543d0907">
                
                

                <div class="wrapped " >
                    
                    <div class="widget-body body body-none  body-compact-all"><div id="sso-urls-div" class="hidden ssoUrls">
    
        <iframe src="//acw.secure.jbs.elsevierhealth.com/SSOCore/update?acw=ec039c4b679ce64b971a222340a5868c0220gxrqa%7C%24%7CEE8BBC64F43CA1491B0BE486A6B387A7BDE26944666D33E52F0C3272A0F4995D24516E485F9EF29CCCE2BB43B8B265274BAE48610A35BC353FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=b6d5d153f4e3271aaf9c972-21eb99cc0b7932f2"></iframe>
    
        <iframe src="//acw.evise.com/SSOCore/update?acw=ec039c4b679ce64b971a222340a5868c0220gxrqa%7C%24%7CEE8BBC64F43CA1491B0BE486A6B387A7BDE26944666D33E52F0C3272A0F4995D24516E485F9EF29CCCE2BB43B8B265274BAE48610A35BC353FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=b6d5d153f4e3271aaf9c972-21eb99cc0b7932f2"></iframe>
    
        <iframe src="//acw.sciencedirect.com/SSOCore/update?acw=ec039c4b679ce64b971a222340a5868c0220gxrqa%7C%24%7CEE8BBC64F43CA1491B0BE486A6B387A7BDE26944666D33E52F0C3272A0F4995D24516E485F9EF29CCCE2BB43B8B265274BAE48610A35BC353FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=b6d5d153f4e3271aaf9c972-21eb99cc0b7932f2"></iframe>
    
        <iframe src="//acw.elsevier.com/SSOCore/update?acw=ec039c4b679ce64b971a222340a5868c0220gxrqa%7C%24%7CEE8BBC64F43CA1491B0BE486A6B387A7BDE26944666D33E52F0C3272A0F4995D24516E485F9EF29CCCE2BB43B8B265274BAE48610A35BC353FBA44D1BD4E4F2EB0469A67597464825D387A21AFA2E514&utt=b6d5d153f4e3271aaf9c972-21eb99cc0b7932f2"></iframe>
    
</div>

<!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.thelancet.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="adafe196-2eed-4691-9a63-5f1e8d920aa3" data-widget-name="UX3HTMLWidget"><!-- Global site tag (gtag.js) - AdWords: 800477382 --> 
<script async src="https://www.googletagmanager.com/gtag/js?id=AW-800477382"></script> 
<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'AW-800477382'); </script></div>

            

        

    

        


    

            

            

            <div data-widget-id="ada4f5c8-9450-4183-89fc-051e378ad5b2" data-widget-name="UX3HTMLWidget"><p class="align-center copy-right">
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the <a href="/cookies" target="_blank">use of cookies</a>.
<br />
Copyright © 2020 Elsevier Inc. except certain content provided by third parties.
<br>
<br>
<a href="https://www.elsevier.com/legal/privacy-policy" alt="Privacy Policy" rel="nofollow" target="_new">Privacy Policy</a>&nbsp;&nbsp;&nbsp;<a href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions" alt="Terms and Conditions" rel="nofollow" target="_new">Terms and Conditions</a>
<br>
<br>
<a href="https://www.relx.com"><img src="//els-jbs-prod-cdn.jbs.elsevierhealth.com/pb/assets/raw/Lancet/images/relx3.png" alt="RELX" rel="nofollow" target="_new"></a>
</p>
<!--
<p class="align-center copy-right">
Copyright © 2020 Elsevier Limited except certain content provided by third parties.
The Lancet is a trade mark of Elsevier Limited.
The Lancet.com website is operated by Elsevier Inc. The content on this site is intended for health professionals.
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the <a href="/cookies">use of cookies</a>.
The Lancet demonstrates its commitment to accessibility by enabling access and optimising the experience for individuals with disabilities and impairments.
</p>
--></div>

            

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="233c371f-f0b7-4cd9-b2b9-1a94969b2c04">
                
                

                <div class="wrapped " >
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.thelancet.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

        


    

            

            

            <div data-widget-id="a6407e18-b243-45d6-bc90-40c68f9b2152" data-widget-name="UX3HTMLWidget"><script>

function scrollToElement(id) {
// USE VARIABLE TO CALCULATE HEIGHT OF COMBINED STICKY BITS
var heightx = 0;
// IF THE HEADER/LOGO ROW EXISTS
if ($(".header__wrapper").length > 0) {
heightx = heightx + $(".header__wrapper").first().height();
}
// IF LEADERBOARD EXISTS
if ($(".widget-horizontalAd").length > 0) {
heightx = heightx + $(".widget-horizontalAd").first().height();
}
// IF ARTICLE TOOLS EXISTS
if ($(".article-tools.sticky").length > 0) {
heightx = heightx + $(".article-tools.sticky").first().height();
//heightx = heightx + $(".article-tools.sticky article-tools__wrapper").first().height();
// allow for padding
heightx = heightx + 26;
}
$('html, body').animate({
scrollTop: $(id).offset().top - heightx + "px"
}, 500);
}

var delay = 3000;
setTimeout(function() {
var relFound = 0;
var relString = "";

$('h2').each(function() {
  var header = $(this).text();
  if (header.indexOf("Related") >= 0) {
   relFound = 1;
   var headID = $(this).attr('id');
   var hrefString = "#" + headID;
   var relString = "<section id='related-section'><div class='section-paragraph' id='related-message-box'><p id='related-message-text'><span>&bull;&nbsp;</span><a id='related-message-link' href='" + hrefString + "'>View related content for this article</a></p></div></section>";
   $("#related-links-container").append(relString);
   $("#related-message-box").css("background-color", "#efefef");
   $("#related-message-box").css("padding", "10px");
   $("#related-message-text").css("padding", "0px");
   $("#related-message-text").css("margin", "0px"); 
   $('a#related-message-link').click(function() {
    scrollToElement(hrefString);
   });
   return false;
  }

});

if (relFound == 0) {
 $( "#related-section" ).hide();    
}

// addition from Andrew, to move the View Related box for Light Blue content
  if ($(".article__body section h2:contains('Summary')").length == 0 && $("h2:contains('Related')").length > 0) {
    $(".section-paragraph:not(:has(.accordion--textbox,figure))").eq(2).after($(".relatedItems-dropzone section#related-section").detach()); 
    $("section#related-section").css("margin-bottom", "0px");   
  }
   
}, delay);

</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="711983b9-6e41-4e08-8776-c6541734fc01" data-widget-name="UX3HTMLWidget"><script type="text/javascript"> _linkedin_partner_id = "402924"; window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || []; window._linkedin_data_partner_ids.push(_linkedin_partner_id); </script><script type="text/javascript"> (function(){var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);})(); </script> <noscript> <img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=402924&amp;fmt=gif" /> </noscript></div>

            

        

    

        


    

            

            

            <div data-widget-id="ee88cfc7-305d-4bc3-88ee-f91eab11add1" data-widget-name="UX3HTMLWidget"><style>
.ad-section .pb-ad {
 display:block;
 height: auto; 
 margin-left: 0px;
 margin-right: auto;
}
.linkback-ad .pb-ad {
 display:block;
 height: auto; 
 margin-left: 0px;
 margin-right: auto;
}
.linkback-ad .pb-ad .linkback-image img {
 max-width:none;
}
.linkback-ad .pb-ad .linkback-link {
 font-weight:700;
}
.linkback-ad .pb-ad .linkback-image-copyright {
 font-size:75%;
}
.linkback-ad .pb-ad .teaserCopyrightMsg {
 font-size:70%;    
}
@media only screen and (min-width: 1500px) {
 .linkback-ad .pb-ad .linkback {
  margin-top:30px;
  display:flex;
 }
 .linkback-ad .pb-ad .linkback-image {
  max-width:35%;
  margin-right:5%;
 }
 .linkback-ad .pb-ad .linkback-text {
  width:auto;
 }
}
@media only screen and (max-width: 1500px) {
 .linkback-ad .pb-ad .linkback {
  margin-top:10px;
 }
 .linkback-ad .pb-ad .linkback-image {
  display: none;
 }
 .linkback-ad .pb-ad .linkback-text {
  width:auto;
 }
}
.noMargin {
  margin: 0 !important;
}
.noPadding {
  padding: 0 !important;
}
</style></div>

            

        

    

        


    

            

            

            <div data-widget-id="1f934032-5497-4118-b197-aec2515a6307" data-widget-name="UX3HTMLWidget"><style>
@media only screen and (min-width: 1500px) {
 .article__tos li a {
 /* word-wrap: normal; */
 padding-left:1px;
 }    
}
@media only screen and (min-width: 1500px) {
 /* looks like the style above has stopped working in 2018.8. So try the below instead */
 .article__body .left-side-nav li a {
  padding-left:1px;
 }    
}
</style></div>

            

        

    

        


    

            

            
                <div class="noMargin">
            

            <div data-widget-id="f8e014fb-0959-477e-8f5b-ccd252852fd6" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code -->
<script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/3798016.js"></script>
<!-- End of HubSpot Embed Code --></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="f13ddc3d-3149-459d-9c0e-1bc041f355f9" data-widget-name="UX3HTMLWidget"><style>
html:not([data-pb-can-design]) .pb-action-bar {
 display:none;
}
.pb-start-action-bar, .pb-start-action-bar .pb-collapse-btn-container, .pb-start-action-bar .pb-main-bar {
    top: 200px !important;
}
</style></div>

            

        

    

        


    

            

            

            <div data-widget-id="29719a1a-7635-4938-bff7-2cd07ffd9649" data-widget-name="UX3HTMLWidget"><style>
.ux3 .adplaceholder--header {
   top: 0;
}
</style></div>

            

        

    

        


    

            

            

            <div data-widget-id="33cab61c-6b21-4e99-887d-28a1e6abe1d8" data-widget-name="UX3HTMLWidget"><script>
// adding this JS as a temp fix to correct the colour of the Quick Search magnifying glass
    // determine Lancet journal color code
    var jCode = $("input[name='journalCode']").attr("value");
    jColor = '#00539e';		// Parent site color	
    if (jCode == "lancet") {
      	jColor = '#4d6a75';
    } else if (jCode == "lanchi") {
       	jColor = '#B0117F';
    } else if (jCode == "landia") {
       	jColor = '#00ab9c';
    } else if (jCode == "landig") {
       	jColor = '#76bfe8';       	
    } else if (jCode == "langas") {
       	jColor = '#677718';
    } else if (jCode == "langlo") {
       	jColor = '#930438';
    } else if (jCode == "lanhae") {
       	jColor = '#f8941d';
    } else if (jCode == "lanhiv") {
       	jColor = '#650360';
    } else if (jCode == "laninf") {
       	jColor = '#936fb1';
    } else if (jCode == "laneur") {
       	jColor = '#6cb33e';
    } else if (jCode == "lanonc") {
       	jColor = '#ee3123';
    } else if (jCode == "lanplh") {
       	jColor = '#009444';
    } else if (jCode == "lanpsy") {
       	jColor = '#00447c';
    } else if (jCode == "lanpub") {
       	jColor = '#487483';
    } else if (jCode == "lanres") {
      	jColor = '#009cd8';
    } else if (jCode == "lanrhe") {
      	jColor = '#9e5572';      	
    } else if (jCode == "eclinm") {
       	jColor = '#004896';
    } else if (jCode == "ebiom") {
       	jColor = '#004896';
    }

    $( ".ux3 .quick-search [type='submit']" ).hover(
     function() {
        $(this).css("background",jColor);
        $(this).css("color","#fff");        
     }, function() {
        $(this).css("background","#fff");
        $(this).css("color","#505050");        
     }
    );
    $( ".ux3 .quick-search [type='submit']" ).focus(
     function() {
        $(this).css("background",jColor);
        $(this).css("color","#fff");        
     }, function() {
        $(this).css("background","#fff");
        $(this).css("color","#505050");        
     }
    );    

</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="9be8925e-9dbc-4133-b2bd-0aee8fde3fb0" data-widget-name="UX3HTMLWidget"><style>
html:not([data-pb-can-design]) .atypon-admin-bar-container {
 display:none !important;
}
</style></div>

            

        
</footer></div>

            

        

        </div>
    
        </div>
    </div>













        
        
            <script type="text/javascript" src="/products/marlin/lancet/releasedAssets/js/main.bundle.js"></script>
        
        


    


    <script type="text/javascript">
        WebFontConfig = {
            google: {
                families: ['Source Sans Pro']
            },
            loading: function () {

            },
            active: function () {
                $(document).trigger("resize");
            }
        };
    </script>
    <script type="text/javascript"
            src="https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js"></script>






<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Public Health,Infectious Diseases,Health Policy,Internal:Family Medicine,General Surgery,Lancet","issn":"0140-6736","name":"The Lancet","section":"Primary Research:Articles"},"page":{"loadTimestamp":"1590185581991","server":"www.thelancet.com","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"The Lancet","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"ae:Journal Branded Solutions - Guests|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:375335|ae:228598","accountName":"ae:Journal Branded Solutions - Guests|ae:ScienceDirect Guests","departmentId":"ae:388406|ae:291352","ipAddress":"178.79.165.171","loginStatus":"anonymous","userId":"ae:19319093|ae:12975512"},"content":[{"accessType":"article:free:standard","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0140673620311806","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID19 a multinational registry analysis","status":"S200"}]};
</script>

<script type="text/javascript">pageDataTracker.trackPageLoad();</script>





















    

</body>
</html>
